Lipid Rafts and Lung Surfactant Secretion by Chintagari, Narendranath Reddy
 LIPID RAFTS AND LUNG SURFACTANT 
SECRETION  
 
 
 
   By 
NARENDRANATH REDDY CHINTAGARI 
   Bachelor of Veterinary Science & Animal Husbandry 
   Acharya N.G.Ranga Agricultural University  
   Hyderabad, India. 
   1999 
 
 
Master of Veterinary Science (Pharmacology) 
Gujarat Agricultural University 
Anand, India. 
2002 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   DOCTOR OF PHILOSOPHY 
  December, 2007 
 ii
      LIPID RAFTS AND LUNG SURFACTANT SECRETION  
 
 
 
 
 
 
   Thesis Approved: 
 
 
Dr. Lin Liu 
Dr. Nicholas L. Cross 
 
Dr. Bret N. Flanders 
 
Dr. Charlotte L. Ownby  
 
Dr. A. Gordon Emslie 
Dean of the Graduate College 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii
ACKNOWLEDGEMENTS 
 
 I take this wonderful opportunity to sincerely express my deep sense of gratitude 
to my major advisor Dr. Lin Liu.  Over the years, I became confident mainly because of 
his constant encouragement, critical suggestions and his ability to bring best out of me. 
His most admirable feature which had a great influence on me was his confidence in lab 
personnel and his perseverance. I convey my deep sense of appreciation for providing us 
such a wonderful platform in the form of lab environment and technical help which 
enabled us to perform better.  
 I would like to convey my gratitude to Drs. Charlotte Ownby, Nicholas Cross and 
Bret Flanders for accepting to serve as members of committee.  Their suggestions have 
enabled me to answer the biological phenomenon under investigation in a better way. 
Their expertise and critique had led us to design new experiments which had improved 
the quality of research.  
 I appreciate and thank Dr. Anthony Confer for allowing me to use his laboratory.  
I convey my special appreciation to Dr. Sahlu for helping me to perform isoelectric 
focusing and 2-D gel electrophoresis. I also want to express my deep sense of gratitude to 
Dr. Steve Hartson for mass spectrometry and finger printing analysis. His eagerness to 
help students in spite of busy schedule is highly appreciable.  
 I would like to specially thank Dr. Narasaraju who had helped me in a great way 
during my early stages of research career. I owe my deep sense of gratitude to him for 
imparting me a sense of appreciation of one’s work, attention to details and ready to help 
 iv
other colleagues. 
 I thank my senior colleagues Drs. Obonyo, Chattopadhay, Jiwang, Howard, Nili, 
Zhongming, Pengcheng, Kexiong for their help and suggestions. I would also thank them 
for letting me be a part of their research also. They have left an indelible mark on us and 
set a competitive atmosphere. I want to convey my appreciation to Drs. Deming, Collin 
and Honghao for their critical suggestions and help. 
 I appreciate and convey my heartfelt thanks to by Drs. Bhaskaran, Baviskar, 
Khushoo, Mishra and Sarathy for their help in times of need. Their presence in the lab 
provided a homely atmosphere and a wonderful place to work. Their encouragement in 
times of need can never be forgotten. I also want to express my sincere thanks to 
Tingting, Yang, Yujie and Lijing for their willingness to help. 
 I would like to sincerely acknowledge Center for Veterinary Health Sciences for 
providing me financial assistantship in the form of Teaching Assistantship. I also want to 
acknowledge the center for providing me two student seed grants which enabled me to 
improve the quality of my research work but also gave me much needed grant writing 
experience. 
 I would like to acknowledge the help rendered by Dr. Charmaine Naidoo, Zhixin 
Wang and Peng Sun. Without their help, it would have almost impossible to get our 
reagents and general lab supplies on time. I would also want to thank Candice Marsh, 
Tisha Posey and Dr. Heidi Stricker for their editorial help.  
 I would like to express my gratitude to Drs. Stein and Watson for their help and 
understanding while I was Teaching Assistant in Gross and Developmental Anatomy of 
Dog. Without their co-operation, it would have been difficult to balance my teaching and 
 v
research duties. I also owe them for imparting me a sense of responsibility and helping 
me improve my teaching skills. 
 I am lucky to have a wonderful wife, Praveena who shared all my agony and 
happiness. She helped me tide over the difficult times and always encouraged me to 
perform better and be a better person. Without her, I think it would have been impossible 
to undertake my research. 
 Last but not the least, I owe my deep sense of gratitude to my parents, Smt. & 
Shri Narasimha Reddy gaaru, in-laws, Smt. & Shri Koti Reddy gaaru, brothers 
Ravindranath and Surendranath, sister-in-laws Vijaya Lakshmi, Aparna, Prasanna and 
niece and nephew Archana and SaiShreetan. Without their encouragement and love, the 
present work would have been impossible.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vi
TABLE OF CONTENTS 
Chapter          Page 
 
I. INTRODUCTION 
 
 Alveolar epithelium .................................................................................................1 
 Lung surfactant composition, synthesis and secretion .............................................2 
 Lipid rafts .................................................................................................................5 
 V-ATPases ...............................................................................................................8 
      Specific aims and significance ...............................................................................10 
 References ..............................................................................................................12 
 
II. EFFECT OF CHOLESTEROL DEPLETION ON EXOCYTOSIS OF ALVEOLAR 
    TYPE II CELLS 
 
 Abstract ..................................................................................................................20 
 Introduction ............................................................................................................22 
 Materials and Methods ...........................................................................................25 
 Results 
 i.      Identification of raft marker proteins .............................................................34 
 ii.     SNARE protein association with lipid rafts...................................................38 
 iii.    Effect of cholesterol depletion on fusion pore formation ..............................43 
 iv.    Effect of cholesterol depletion on membrane fusion .....................................49 
 v.     Effect of cholesterol depletion on surfactant secretion by type II cells .........52 
 vi.    Co-localization of SNARE proteins with raft clusters ...................................53 
 vii.   Annexin A2 and raft clustering ......................................................................56 
 Discussion ..............................................................................................................59 
 References ..............................................................................................................64 
 
III. KNOCKDOWN OF FLOTILLIN-2 INHIBITS LUNG SURFACTANT SECRETION  
      BY ALVEOLAR TYPE II CELLS 
 
 Abstract ..................................................................................................................68 
 Introduction ............................................................................................................69 
 Materials and Methods ...........................................................................................71 
 Results 
 i.      Knockdown of flotillins in L2 cells ...............................................................75 
 ii.     Effect of flotillin silencing on surfactant secretion ........................................79 
 iii.    Effect of flotillin silencing on raft formation ................................................81 
 iv.    Effect of flotillin silencing on SNARE protein association with membrane  
         rafts ................................................................................................................81 
 vii
v.     Effect of flotillin silencing on cholesterol content ...............................................83 
 Discussion ..............................................................................................................84 
 References ..............................................................................................................87 
 
IV. VACUOLAR ATPases: POTENTIAL ROLES IN LUNG SURFACTANT 
SECRETION BY ALVEOLAR TYPE II CELLS 
 
 Abstract ..................................................................................................................90 
 Introduction ............................................................................................................91 
 Materials & Methods .............................................................................................95 
 Results 
 i.      2-D gel electrophoresis ................................................................................101 
 ii.     Association of V-ATPase subunits with lipid rafts .....................................106 
 iii.    Differential expression of V-ATPase subunit .............................................107 
iv.    Effect of V-ATPase inhibition on lamellar body pH and surfactant 
        secretion .......................................................................................................108 
v.     Effect of Ca2+- chelators and thapsigargin on V-ATPase mediated surfactant    
secretion .........................................................................................................111 
vi.    Effect of PKC and CaMKII inhibition on V-ATPase mediated surfactant  
        secretion .......................................................................................................113 
vii.   V-ATPase is inhibited during secretion .......................................................116 
 Discussion ............................................................................................................118 
 References ............................................................................................................123 
 
V.  SUMMARY AND CONCLUSIONS ..................................................................129 
 
APPENDIX ................................................................................................................132 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii
LIST OF TABLES 
 
Table           Page 
 
II. 1.   Differential association of proteins with lipid rafts of alveolar type II cells .....41 
II. 2.  Quantification of fusion pore formation .............................................................45 
IV.1. Proteomic profile of lipid rafts isolated from alveolar type II cells .................104 
 
 
 ix
LIST OF FIGURES 
Figure           Page 
 
II.1. Identification of lipid raft marker proteins in alveolar type II cells .....................36 
II.2. Effect of cholesterol depletion on SNARE protein association with lipid rafts ...41 
II.3. Cholesterol depletion inhibits the fusion pore formation in type II cells .............48 
II.4. Cholesterol depletion alters membrane fusion activity ........................................50 
II.5. Effect of cholesterol depletion on surfactant secretion ........................................52 
II.6. SNARE proteins co-localize with raft clusters ....................................................55 
II.7. Annexin A2 co-localizes with lipid raft clusters ..................................................58 
III.1. Knockdown of flotillin-1 and flotillin-2 .............................................................77 
III.2. Effect of flotillin silencing on surfactant secretion .............................................80 
III.3. Effect of flotillin silencing on membrane raft formation ....................................82 
III.4. Effect of flotillin silencing on cholesterol content ..............................................83 
IV.1. 2-D Gel electrophoresis of type II cell lipid rafts .............................................103 
IV.2. Association of V-ATPase subunits with lipid rafts ..........................................106 
IV.3. Differential expression of V-ATPase subunits .................................................107 
IV.4. Effect of Baf A1 on pH gradient of lamellar bodies and surfactant secretion ..109 
IV. 5. Effect of Ca2+-chelators and thapsigargin on V-ATPase mediated surfactant 
secretion ...............................................................................................................112 
IV.6. Effect of PKC and CaMKII inhibitors on V-ATPase mediated surfactant secretion
..............................................................................................................................115
 x
IV. 7. Monitoring of lamellar body pH following stimulation of type II cells ..........117 
IV.8. Schematic representation of proposed events following V-ATPase inhibition ......
..............................................................................................................................122 
 xi
ABBREVIATIONS 
 
α-SNAP     α-Soluble N-ethylmaleimide-sensitive  
      fusion protein Attachment protein 
Type I      Alveolar type I cells 
Type II     Alveolar type II cells 
ATP      Adenosine triphosphate 
BAPTA-AM     Bis-(o-aminophenoxy) ethane-N,N,N´,N´- 
      tetraacetic acid acetoxymethyl ester 
 
BSA      Bovine Serum Albumin 
CaMKII     Ca2+/Calmodulin-dependent protein kinase II 
CMV      Cytomegalovirus 
DMEM     Dulbecco's Modified Eagle's Medium 
DPPC      Dipalmitoylphosphatidylcholine 
ECL      Enhanced Chemiluminescence 
EGTA     Ethylene Glycol-bis-(3-aminoethyl  
     ether) N, N’-Tetraacetic Acid 
EDTA      Ethylene Diamine Tetraacetic Acid  
EHS      Engelbroth-Holm-Swarm  
ER      Endoplasmic reticulum 
FBS      Fetal Bovine Serum 
FM1-43     N-(3-triethylammonium propyl)-4- 
 
 xii
(dibutilamino)styryl-pyrodinum dibromide 
 
FRET      Fluorescence resonance energy transfer 
GAPDH     Glyceraldehyde Phosphate Dehydrogenase 
EGFP      Enhanced Green Florescent Protein 
GPI      Glycosylphosphatidylinositol  
HRP      Horse Raddish Peroxidase 
HEPES     (2-[4-(2-hydroxyethyl)-1- 
      piperazinyl]ethanesulfonic acid)  
IEF      Isoelectric focusing  
IgG      Immunoglubulin 
kDa      kiloDalton 
KGF      keratinocyte growth factor 
LB-180     Lamellar body membrane protein-180 kDa 
MALDI-TOF   matrix-assisted laser desorption/ionization- 
   Time-of-flight 
MCD      methyl-β -cyclodextrin 
MEM      Minimum Essential Medium 
MES   morpholine-ethanesulfonic acid  
MBS   MES Buffered Saline 
μg   micrograms 
mg      milligram 
MOI      Multiplicity of Infection 
ml      milliliters 
 xiii
MLE      mouse lung epithelial cells 
mRNA      Messenger RNA  
MTT      3-(4,5-dimethylthiazol-2-yl)-2,5- 
      diphenyltetrazolium bromide 
NP-40      Nonidet P-40  
NSF      N-ethylmaleimide sensitive factor  
PBS      Phosphate buffered Saline 
PC      Phosphatidylcholine 
PC12       Pheochromocytoma cells  
PKC      Protein Kinase C 
PKA      Protein Kinase A 
PMSF      Phenylmethylsulfonyl fluoride 
PS      Phosphatidylserine 
R-18      Octadecyl Rhodamine 
RDS      Respiratory distress syndrome  
RNAi      RNA interference 
rRNA      ribosomal RNA 
RT-PCR     Reverse transcriptase PCR  
SDS-PAGE Sodium Dodecyl Sulfate-Polyacrylamide 
Gel Electrophoresis  
SNARE     soluble N-ethylmaleimide-sensitive fusion  
      protein attachment protein receptors 
SNAP-23/25     Synaptosome-associated protein of 23/25  
 xiv
SP-C      Surfactant protein C  
TTBS      Tween-Tris-Buffered Saline 
VAMP      Vesicle associated membrane protein 
V-ATPase     Vacuolar ATPase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
CHAPTER I 
 
INTRODUCTION 
1.1 Alveolar epithelium  
 The lung alveoli are the basic and functional units involved in gaseous exchange. 
The lungs undergo constant expansion and compression during the process of respiration. 
Lung alveoli are lined with lung surfactant that reduces surface tension to prevent the 
collapse of alveoli at the end of expiration. Lungs are also frequently exposed to harmful 
microbes, toxins and pollutants. The alveoli are equipped with defense mechanisms to 
counteract the pathogens. The cell types that line the alveoli are uniquely adapted to 
withstand the constant mechanical stretch and to function under dynamic conditions. The 
cells in the lung also communicate by a paracrine or autocrine manner to regulate lung 
functions (1).   
 The alveoli are lined by two distinct epithelial cells, the squamous alveolar type I 
(type I) cells and cuboidal type II cells. They perform distinct and diverse functions. Type 
II cells constitute two-thirds of alveolar epithelial cell populations whereas type I cells 
form the other remaining one-third of the population. However type I cells occupy 95% 
of the surface area owing to their large size. Type I cells are involved in gaseous 
exchange, fluid homeostasis and act as mechano-sensors for the stretch that is induced 
during the respiratory process (2).   
Type II cells secrete antimicrobial peptides including defensins. They act as 
progenitors for type I cells and replace the injured type I cell population. Additionally 
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type II cells are involved in fluid homeostasis (3). Another major function of type II cells 
is to synthesize, store and secrete lung surfactant. Deficiency of surfactant leads to acute 
respiratory distress syndrome in infants and is characterized by alveolar collapse and in 
extreme cases leads to death.  The current study investigates the functions of type II cells, 
in particular surfactant secretion. 
1.2 Lung surfactant composition, synthesis and secretion 
 The lung surfactant is a lipid-rich substance consisting of 90-95% lipids and about 
5-10% proteins. Phospholipids constitute 80% and the remaining 20% are contributed by 
neutral (such as cholesterol) and other lipids.  Dipalmitoylphosphatidyl choline is 
responsible for lowering surface tension.   
The protein components of lung surfactant include surfactant protein –A, B, C and 
D (SP-A, B, C and D). They are synthesized in the endoplasmic reticulum and are further 
processed in Golgi. The proteins (SP-B and SP-C) are stored in lamellar bodies until 
released. SP-B and –SP-C are secreted along with surfactant lipids in a regulated manner 
(4, 5).  However, SP-A and –D are secreted in a constitutive fashion and independent of 
lamellar bodies (6). The secreted SP-A and SP–B aids in the formation of tubular myelin, 
a precursor of the surfactant monolayer at the air-liquid interface. On the other hand, the 
secreted SP- B and SP-C help in the adsorption and distribution of surfactant. Apart from 
surfactant related functions, surfactant proteins are also involved in alveolar defense (7).   
  Physiologically, type II cells are stimulated by mechanical stretch induced by 
labor and ventilation. Stretch induces an increase in intracellular Ca2+ ([Ca2+]i),  which 
propagates as a wave to the neighboring type II cells through gap junctions. The net 
increase in [Ca2+]i results in surfactant secretion (8, 9). Type II cell exocytosis is 
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extremely sensitive to fluctuations in [Ca2+]i (10). However, Ca2+ sensors in type II cells 
are unknown, but, the role of annexin A2 as a possible sensor is proposed (11).   
 Natural agonists including ATP, UTP, adenosine, platelet activating factor, 
lipopolysaccharide and IL-1 also stimulate surfactant secretion.  A number of compounds 
including β2-adrenergic agonists (terbutaline), A2B receptor agonists (adenosine), P2Y2 
receptor agonists (ATP and UTP), protein kinase C activators (phorbol esters) and 
calcium ionophores (A23187) stimulate surfactant secretion (12). Terbutaline and 
adenosine activate adenyl cyclase which further activates protein kinase A. On the other 
hand, ATP and phorbol esters activate PKC. The ionophores increase the [Ca2+]i which 
activates PKC and Ca2+/calmodulin-dependent kinase II. The activation of various 
kinases leads to phosphorylation of exocytotic proteins. However, the mechanism of how 
the phosphorylation induces lung surfactant secretion is poorly understood.   
 Exocytosis involves the interaction of proteins present on the lamellar bodies and 
plasma membrane (13). The soluble N-ethylmaleimide sensitive factor attachment protein 
receptor (SNARE) hypothesis was proposed to explain eukaryotic membrane fusion 
machinery. According to the SNARE hypothesis, during membrane fusion, the proteins 
residing on the vesicle or v-SNAREs (on lamellar bodies in type II cells) interact with 
those on plasma or target membrane or t-SNAREs to form a highly stable coiled-coil 
ternary SNARE complex. One coil each is contributed by vesicle associated membrane 
protein (VAMP) and syntaxin and two by SNAP-25.  Later, N-ethylmaleimide sensitive 
factor (NSF), an ATPase along with its adaptor protein, α-souble NSF attachment protein 
(α –SNAP), binds the SNARE complex, separating the interacting SNARE partners for 
subsequent rounds of exocytosis. In vitro the formation of SNARE complex is sufficient 
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for close apposition and membrane fusion. The vesicular contents are released through a 
fusion pore. Evidence for the involvement of SNARE proteins in membrane fusion is 
strengthened with a recent study which revealed that transmembrane regions of syntaxin 
protein line the fusion pore (14).  
 More than 30 SNARE isoforms are reported in mammals, all of which are 
characterized by conserved aminoacids sequences close to the membrane anchors which 
form the coiled-coiled structures (15). There are about 15 syntaxin isoforms which 
inhabit various membranes. Syntaxins 1-4 are involved in exocytosis.  Syntaxins 
associate with membrane by a transmembrane anchor at the C-terminus of the protein.  
Syntaxins are associated with nSec1/Munc18-1 thus limiting the availability of this 
protein for interaction. However, following the activation of small GTPases, Rab 
proteins, the syntaxin is released from nSec1 for subsequent interaction (16). SNAP-
25/23 proteins associate with membrane owing to multiple palmitoylations on the 
cysteine residues.  Seven different forms of VAMP proteins are reported. They are 
anchored to the membrane by a transmembrane domain.  The membrane fusion 
machinery in type II cells contains t-SNAREs (syntaxin-2 and SNAP-23) and v-SNARE, 
VAMP-2, apart from α-SNAP and the ATPase, NSF (17, 18).   
 A number of studies from our laboratory had indicated the role of annexin A2 in 
surfactant secretion (11, 19, 20). Annexins are cytosolic proteins that bind with 
phospholipid membranes in a Ca2+-dependent manner. Annexin A2 facilitates not only 
aggregation of liposomes but also promotes the fusion of lamellar bodies with plasma 
membranes (21-23). Moreover, annexin A2 mediates cortical actin disassembly 
facilitating surfactant secretion (24). The knockdown of annexin A2 in type II cells 
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results in reduced secretion, indicating its crucial role in secretion (19, 20). Annexin A7 
has also been shown to be involved in surfactant secretion (25, 26). 
1.3 Lipid rafts 
 Cell membranes consist of mixtures of lipids and proteins. According to the raft 
hypothesis, the lipid bilayer consists of saturated and unsaturated lipids. Saturated lipids 
confer an ordered (Io) or gel phase whereas unsaturated lipids confer disordered (Id) or 
liquid phase to the membrane. These ordered domains (lipid rafts) are enriched in 
glycosphingolipids, cholesterol and sphingomyelin. Lipid rafts are defined as “small (10–
200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched domains that 
compartmentalize cellular processes. Small rafts can sometimes be stabilized to form 
larger platforms through protein-protein and protein-lipid interactions" (27). The lipid 
composition of lipid rafts renders them insoluble to ice-cold 1% TX-100 (v/v) 
solubilization and they float when subjected to sucrose gradient centrifugation. They are 
hence called detergent resistant or detergent insoluble membrane fractions. Since lipid 
rafts are highly enriched in cholesterol, its enrichment following isolation and cholesterol 
dependent association of proteins should be confirmed. The unique lipid composition of 
lipid rafts enrich them in proteins that are doubly acylated (Src kinases), cholesterol- 
binding (caveolins), myristoylated and palmitoylated (flotillins) and GPI-anchored. By 
sequestering proteins and lipids, membrane microdomains exert influence not only on 
protein-protein interaction but also protein-lipid and lipid-lipid interactions.  Thus lipid 
rafts serve as regulatory centers in various physiological conditions. They are reported to 
be crucial in a number of metabolic and pathogenic diseases (28). During resting 
conditions lipid rafts contain few proteins, however, upon stimulation, they cluster and 
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recruit additional proteins (29). They are thus ideally suited for membrane traffic, signal 
transduction, and protein sorting in polarized epithelial cells as well as non-polarized 
cells (30).  
SNARE proteins associate with lipid rafts (31-33), although in vitro studies revealed 
that SNARE proteins prefer disordered phases more than ordered (34). In LT3 
adipocytes, PC12 and HIT-T15 cells, SNARE proteins are enriched in rafts with SNAP-
25/23 to a higher extent (35-37).   SNAP-23 has a higher enrichment than its neuronal 
isoform, SNAP-25, due to its additional cysteine residues (37). The enrichment of v-
SNARE is variable with the highest in LT3 cells.  However, it was also reported that in 
PC12 cells, syntaxin was detergent soluble and did not co-localize with the raft markers 
(38). All the studied SNARE regulatory proteins are efficiently excluded from rafts. 
Moreover, SNARE complexes are highly enriched in raft fractions, indicating that rafts 
could be the sites of exocytosis (35). Similarily, Munc18-2/syntaxin3 complexes were 
excluded from the rafts indicating that a spatial control exists (39). Cholesterol depletion 
results in altered exocytosis indicating a role of lipid rafts in regulated exocytosis. In 
summary, raft association of SNARE proteins might pave a way for the interaction of 
SNARE proteins and provide suitable lipid environment for the membrane fusion. 
However, there are no reports of SNARE protein organization in type II cells. 
 Annexin A2 translocates to the Triton X-100 insoluble fractions in bovine 
chromaffin cells upon stimulation. Annexin A2 is associated with the lipid raft clusters in 
a Ca2+-dependent manner (40, 41). Cleavage of annexin A2 abolishes its binding with the 
rafts, indicating that alteration in protein structure may affect its association with rafts 
(42). Moreover, annexin A2 promotes the formation of lipid microdomains and organizes 
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the exocytotic machinery (43). There are no reports on raft association of annexin A2 in 
alveolar type II cells. 
 Downregulation or knockdown of raft marker proteins have been undertaken to 
elucidate their roles (44).  Caveolin-1 knockdown results in the loss of caveolae, the 
plasma membrane invaginations. Type II cells lack distinct caveolae in contrast to AT1 
cells. Flotillins on the other hand are highly expressed in type II cells and hence can be 
used as marker proteins to study their roles in lipid rafts formation and surfactant 
secretion. 
 Flotillins (or reggies) are highly conserved and ubiquitously expressed. There are 
two flotillin isoforms, namely -1 (or reggie-2) and -2 (or reggie-1). Different cell types 
may express both or one of the isoforms. Initially, flotillins were thought to be caveolae-
associated proteins. However, it has been shown that its expression is independent of 
caveolae. Flotillins do not have a distinct transmembrane domain. They associate with 
rafts owing to the multiple palmitoylation in case of flotillin-1 and additionally 
myristoylation in case of flotillin-2. Nuclear localization of flotillin-1 but not -2 has also 
been reported in PC-3 cells (45). The distribution of these proteins thus enable to them to 
be involved in a number of cellular functions.  
Flotillins are implicated in a number of functions including interactions with actin 
cytoskeleton, formation of filopodia, insulin signaling, axonal regeneration and 
membrane trafficking (46). Their association with kinases (such as Thy-1) and cell 
adhesion molecules such as F3 implicates them in signal transduction and the 
establishment of cell-cell contacts (47). Its role in clathrin-independent endocytosis has 
been recently reported (48). Silencing or mutation studies in Zebra fish and Drosophila 
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has indicated the importance of these proteins in embryogenesis. Other studies have 
indicated that flotillins are involved in neuroprotection following ischemic and 
reperfusion injury and in progression of Alzheimer pathology (49, 50).  The role of 
flotillins in the formation of membrane rafts has been speculated (51).   
 Lipid rafts sequester only specific groups of proteins while excluding others. 
Some proteins specifically translocate into lipid rafts under certain patho-physiogical 
conditions from non-raft compartments. Similarly, a vice-versa phenomenon was also 
reported. Such reports indicate the compositional complexity and the need to critically 
evaluate the lipid raft association of proteins. Proteomic profiling provide a tool to reveal 
the protein component of these microdomains. 
 Lipid raft proteomic analysis has been previously reported in various cell types 
including monocytes (52), sperm cells (53), Jurkat T-cell line (54), HeLa cell line (55), 
human endothelial cells (56), neutrophils (57) and the rat liver (58). These studies have 
revealed that raft protein machinery is diverse and specific to each cell type. The 
identified proteins are important in the functioning of endoplasmic reticulum, early and 
late endosome trafficking, phagosomes, mitochondria, cytoskeletal assembly and signal 
transduction. Some of the proteins such as V-ATPases, Ca+2-ATPases, SNARE proteins, 
annexins, Rab proteins and myelin vesicular protein of 17 kDa (MVP17) are involved in 
membrane fusion and vesicular trafficking. However, there are no reports on the 
complete proteomic profile of type II cell lipid rafts.  
1.4 V-ATPases 
 V-ATPases are multi-subunit enzymes which drive the movement of protons 
against the concentration gradient using the energy of ATP hydrolysis. During this 
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process they generate a transvesicular proton-electrochemical potential gradient (Δψv) 
and a transvesicular pH gradient (ΔpHv). 
Structurally, V-ATPases consists of a peripheral catalytic unit, V1 and a 
transmembrane proton translocator, VO. The catalytic unit contains 8 subunits (A-H) 
whereas the proton translocator contains 5 subunits labeled a, c, c´, c´´ and d. V-ATPases 
are predominantly localized on the intracellular organelles such as lysosomes, 
endosomes, chromaffin granules, clathrin-coated and synaptic vesicles in a number of 
cell types including sperm, kidneys and macrophages (59). Plasma membrane 
localization of V-ATPases is reported in osteoclasts, renal intercalated cells, interdental 
cells of inner ear, narrow and clear cells in the epididymus and vas deferens (60). The 
altered plasma membrane V-ATPase activity results in bone resorption, renal 
acidification, and spermatogenesis (61, 62).  
Various isoforms for each of the subunits were reported with tissue specific 
localization patterns. For example, a1 and a2 localised to organelles other than lysosomes 
whereas a3 to endosomes and lysosomes in murine macrophages (63). Such expression 
patterns implicated V-ATPases in diverse tissue specific functions and also inherent 
differences in regulation of H+ pumping activity.   
Previous studies have indicated the expression of different subunits in bovine, rat 
and mouse lungs such as a1, a2, a3, c2-a, e1, d1, d2, G1 (64-66). In rat lung type II cells, 
a and e1 mRNA are stably expressed encoding until 4 days after isolation, whereas c2 
expression is drastically reduced by 1 day after isolation (67). The c2-a isoform co-
localised with the mouse lamellar body membrane protein, LB-180 (68). The differential 
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expression of protein subunits might indicate either the regulation of enzyme activity or 
its role in lamellar body functions.  
V-ATPases on intracellular organelles are involved in secretory processes such as 
the uptake and processing of secretory proteins including serotonin, histamine and 
glutamic acid (69, 70). V-ATPases play a role in exocytosis processes such as the 
formation of the fusion pore and membrane fusion (71, 72). V-ATPase a1 and c subunits 
interact with SNARE proteins and are crucial in late stages of vesicular exocytosis (73-
76). In a3 knockout mice, normal acidification and processing of insulin in granules took 
place in the absence of a3 protein. However, insulin secretion was decreased, indicating 
that V-ATPase also functions downstream of the acidification (77).  
Lung lamellar bodies maintain acidic pH (78). The acidic pH is essential for the 
processing of SP-C, aggregation and condensation of surfactant lipids (79, 80) 
Additionally Ca2+ uptake was also dependent on acidification (81). Earlier studies utilized 
methylamine or NH4Cl for disrupting the lamellar body pH (82). However, these agents 
increase cytoplasmic pH along with lamellar body pH. It hence becomes difficult to 
deduce the effects of disrupting lamellar body pH and its effect of surfactant.  There are 
no studies on the role of V-ATPases in lung surfactant secretion.  
1.5 Specific aims and significance 
Role of lipid rafts had been studied in PC12, LT3, mast cells, sperm cells, and 
pancreatic-alpha cells. Type II cells are unique, since the exocytosis is slower when 
compared to other systems.  Thus, it might be possible that lipid rafts might serve as one 
of the regulatory mechanisms. Moreover, there is no study on the role of lipid rafts in 
surfactant secretion. Thus, the present study was designed to study lipid raft organization 
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of type II cell surfactant protein machinery. To this end, we have laid down three specific 
objectives: 
Specific Aim I: Investigate the role of lipid rafts in surfactant secretion, 
membrane fusion and fusion pore formation.   
Specific Aim II:  Examine the role of lipid raft marker proteins, flotillin-1 and -2 
in the biogenesis of lipid rafts and surfactant secretion.  
Specific Aim III: Determine the proteomic profile of type II cell lipid rafts and 
functions of identified protein, V-ATPase.   
The study hence would be the first of its kind to implicate lipid rafts in general 
and flotillin and V-ATPase proteins specifically in surfactant secretion.  
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CHAPTER II 
 
EFFECT OF CHOLESTEROL DEPLETION ON EXOCYTOSIS OF ALVEOLAR 
TYPE II CELLS 
 
2.1 Abstract 
Alveolar epithelial type II cells secrete lung surfactant via exocytosis. Soluble N-
ethylmaleimide-sensitive factor attachment protein receptors (SNARE) are implicated in 
this process. Lipid rafts, the cholesterol- and sphingolipid-rich microdomains, may offer a 
platform for protein organization on the cell membrane. We tested the hypothesis that 
lipid rafts organize exocytotic proteins in type II cells and are essential for the fusion of 
lamellar bodies, the secretory granules of type II cells, with the plasma membrane. The 
lipid rafts, isolated from type II cells using 1% Triton X-100 (v/v)  and sucrose gradient 
centrifugation, contained the lipid raft markers, flotillin-1 and -2 whereas excluded the 
non-raft marker, Na+-K+ ATPase. SNAP-23, syntaxin 2 and VAMP-2 were enriched in 
lipid rafts. When type II cells were depleted of cholesterol, the association of SNAREs 
with the lipid rafts was disrupted and the formation of fusion pore was inhibited. 
Furthermore, the cholesterol-depleted plasma membrane had less ability to fuse with 
lamellar bodies, a process mediated by annexin A2. The secretagogue-stimulated 
secretion of lung surfactant from type II cells was also reduced by methyl-beta-
cyclodextrin. When the raft-associated cell surface protein, CD44, was cross-linked using 
anti-CD44 antibodies, the CD44 clusters were observed. Syntaxin 2, SNAP-23, and 
annexin A2 co-localized with the CD44 clusters. Our results suggested that lipid rafts 
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may form a functional platform for surfactant secretion in alveolar type II cells, and raft 
integrity was essential for the fusion between lamellar bodies with the plasma membrane.  
 
Key words: Lipid rafts, SNARE proteins, alveolar type II cells, membrane fusion, 
surfactant secretion, exocytosis 
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2.2 Introduction 
Lung alveolar epithelium consists of two different types of cells, the cuboidal type 
II cells and squamous type I cells.  Type II cells synthesize, store, and secrete a surface-
active lipid-rich substance, the lung surfactant. The released surfactant lines the alveolar 
epithelium, lowers the surface tension, and thus prevents the collapse of alveoli at end-
expiration. Lung surfactant deficiency causes Respiratory Distress Syndrome (RDS) in 
infants. Type II cells are also involved in defense, injury and repair, and trans-
differentiation into type I cells. 
 Lung surfactant, stored in lamellar bodies, is released upon its fusion with the 
plasma membrane via exocytosis. The formation of fusion pore precedes the release of 
lamellar body contents. The SNARE hypothesis was proposed to elucidate the 
mechanisms of membrane fusion during exocytosis. During fusion, the proteins on the 
plasma membrane (target or t-SNAREs) and vesicles (vesicular or v-SNARE) form a 
highly stable, hetero-tetrameric SNARE complex. The two coiled-coil domains are 
contributed by SNAP-25/23 and one each from syntaxin and VAMP (1). NSF, an 
ATPase, binds to its ligand, α-SNAP, and then to the SNARE complex to dissociate it 
and, thus, recycling the interacting components for subsequent cycles. In vitro studies 
have revealed that SNARE complex formation suffices membrane fusion (2), but in vivo 
fusion is a much faster and more complex phenomenon due to the existence of numerous 
SNARE regulatory proteins. The transmembrane regions of syntaxin appear to line the 
fusion pore (3). Previous studies from our laboratory have indicated that syntaxin 2, 
SNAP-23, α-SNAP, and NSF were required for surfactant secretion (4,5).  
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Annexins are a family of highly conserved proteins known for their Ca2+- 
dependent association with the negatively charged phospholipids. Some of the members 
mediated aggregation, as well as the fusion of liposomes. Annexin A2 tetramer had an 
exceptionally low Ca2+ requirement for inducing the membrane fusion. Annexin A2 
tetramer has been reported not only to promote the fusion of lamellar bodies with 
liposomes or the plasma membrane at µM Ca2+ concentrations, but also to reconstitute 
surfactant secretion in permeabilized type II cells (6,7).  The silencing of annexin A2 by 
RNA interference in primary cultures of alveolar type II cells significantly reduced the 
surfactant secretion (8).  
The studies during the past decade have revolutionized the understanding of 
membrane organization. According to the newly proposed raft hypotheses (9,10), 
membrane lipids exist in two phases, ordered phase rendered by saturated lipids and 
disordered phase by unsaturated lipids. The ordered phase lipids form lipid microdomains 
or lipid rafts, which are rich in cholesterol, sphingolipids, and gangliosides, and are 
reported to sequester and segregate a number of specific proteins. Thus, they are ideally 
suited for various processes, including membrane traffic, signal transduction, and apical 
protein sorting (9). Their involvements in other functions are being reported regularly. 
The resident raft proteins include GPI-anchored proteins on the exoplasmic leaflet and 
doubly acylated proteins, and palmitate-anchored proteins on the cytoplasmic leaflet. 
With their unique property of clustering, these microdomains provide an interacting 
platform for the various proteins to bring about the ultimate cellular response. 
SNARE proteins have been shown to be associated with the lipid rafts in several 
cell types (11-14). However, when constituted into giant unilamellar vesicles, syntaxin 
 24
1A and synaptobrevin 2 preferred disordered domains (15). There are no reports of 
SNARE protein organization in type II cells. Furthermore, whether lipid rafts participate 
in the formation of fusion pore and thus membrane fusion was unclear. We hypothesized 
that lipid rafts organize SNARE proteins on the plasma membrane of alveolar type II 
cells and are essential for the fusion of lamellar bodies and the plasma membrane during 
exocytosis. To this end, we isolated lipid rafts from type II cells and determined the 
association of SNARE proteins with the lipid rafts. We further determined whether the 
disruption of lipid rafts by the depletion of cholesterol affected fusion pore formation, 
membrane fusion and surfactant secretion. Additionally, a raft-associated cell surface 
transmembrane glycoprotein, CD44, was cross-linked to form raft clusters using anti-
CD44 antibodies and we determined whether the raft clusters contained exocytotic 
proteins was determined. 
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2.3 Materials and Methods 
2.3.1 Materials 
All chemicals and reagents were of analytical grade and purchased from Sigma 
(St. Louis, MO), unless otherwise stated. Elastase was purchased from Worthington 
Chemicals (Lakewood, NJ). Fetal bovine serum (FBS) was from Gibco (Grand Island, 
NY). Minimal essential medium (MEM) was from ICN Biomedicals (Aurora, OH). 
Nitrocellulose membrane was from Schleicher & Schuell (Keene, NH). Horseradish 
peroxidase (HRP)-conjugated goat anti-rabbit antibody, and protein molecular mass 
markers were from Bio-Rad (Hercules, CA). Cy3-conjugated anti-mouse IgG, HRP-
conjugated goat anti-mouse antibodies and bovine serum albumin (BSA) were from 
Jackson Immunologicals (West Grove, PA). Paraformaldehyde was from Electron 
Microscopy Services (Ft. Washington, PA). Monoclonal anti-flotillin-1 and -2, anti-α-
SNAP, anti-NSF, and anti-CD44 antibodies were from BD Transduction Laboratories 
(Lexington, KY). Monoclonal anti-Na+-K+ATPase antibodies were from Upstate 
Biotechnology (Lake Placid, NY). Monoclonal anti-LB180 antibodies were from 
Covance Research products (Richmond, CA). Polyclonal rabbit anti-syntaxin 2 and anti-
SNAP-23 antibodies were from Synaptic Systems (Gottingen, Germany). Polyclonal 
rabbit anti-VAMP-2 antibodies were from Stressgen (Victoria, Canada). Polyclonal goat 
anti-SP-C antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). 
Amphiphilic dye, N-(3-triethylammoniumpropyl)-4-(4-[dibutylamino]styryl) pyridinium 
dibromide (FM 1-43), Octadecyl rhodamine B chloride (R18), all Alexa-conjugated 
secondary antibodies and cholesterol assay kit were purchased from Molecular Probes 
(Eugene, OR). Enhanced chemiluminescence (ECL) detection system was from 
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Amersham Biotech (Piscataway, NJ). Polyclonal anti-annnexin A2 antibodies were raised 
in rabbits against isolated bovine annexin A2 and were affinity-purified. TRI reagents 
were from Molecular Research Center (Cincinnati, OH). 
2.3.2 Isolation and culturing of alveolar type II cells  
Alveolar type II cells were isolated from male Sprague-Dawley rats (175-200 
gms) as previously described (16). The perfused lungs were lavaged, digested with 
elastase, chopped and filtered. The cells were subjected to IgG panning to remove 
contaminating macrophages. The unattached cells were pelletted, resuspended in MEM, 
counted for number, and assayed for viability using trypan-blue exclusion assay. The cell 
viability ranged from 95-97%. Purity of the cells was greater than 90%, as ascertained by 
Papanicolou’s staining. For the RT-PCR experiment, >96% pure freshly isolated type II 
cells were obtained by our recently modified protocol (17), in which an additional step, 
using anti-leukocyte common antigen antibodies and magnetic beads, was included to 
remove the residual macrophages.  
For studying the differential expression of flotillins, isolated type II cells were 
plated on 35 mm2 plastic dishes at a density of 1.5×106 per dish. The cells were cultured 
for 3 or 7 days in MEM supplemented with 10% FBS. Media was changed after 
overnight culture and then every other day. In this culture system, type II cells loose their 
phenotypes and convert to the type I-like cells with some characteristics of alveolar type I 
cells.  
2.3.3 RT-PCR  
Total RNA was isolated from the lung by homogenizing the tissue in TRI reagent 
or from freshly isolated type II cells by dissolving them in the reagent. The mRNA (1 μg) 
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was reverse-transcribed to cDNA using M-MLV reverse transcriptase and random 
hexamer primers and PCR-amplified using gene specific primers against caveolin-1α 
(Forward: 5’-AAATTGATCTGGTCAACCGC-3’; Reverse: 5’-
ATCTCTTCCTGCGTGCTGAT-3’), caveolin-1β (Forward: 5’- 
ATTGGTTTTACCGCTTGCTG-3’; Reverse: 5’-ATCTCTTCCTGCGTGCTGAT-3’), 
caveolin-2 (Forward: 5’-CTTCATTGCGGGTATCCTGT-3’; Reverse: 5’-
CAGTTGTGGCTCAGTTGCAT-3’), caveolin-3 (Forward: 5’-
GGACATTGTGAAGGTGGATTT-3’; Reverse: 5’-GCACTGGATCTCAATCAGGTA-
3’), flotillin-1 (Forward: 5’-GCTGAAGAAAGCCACCTACG-3’; Reverse: 5’-
CTCAGCTTCAGCTTCTGCCT-3’), flotillin-2 (Forward: 5’-
GGGTACAAGGGTTCTGCGTA-3’; Reverse: 5’-TCTGTGCCTCTATGGTGCAG-3’). 
18S rRNA was amplified using classic 18S RNA primer pairs (Ambion, Austin, TX). The 
conditions for PCR amplification were: 10 mM Tris-HCl (pH 9.0), 50 mM KCl and 0.1% 
Triton X-100, 1.6 mM MgCl2, 0.16 mM dNTP mix, 1.6 μM of each primer, 1 unit DNA 
Taq polymerase and 20 ng of cDNA in a final reaction volume of 25 μl. The thermal 
conditions were  940C for 2 min, 35 cycles of  940C  30 sec, 550C  40 sec, 720C 1 min, 
followed by 720C for 8 min. The PCR products were electrophoretically separated on 
agarose gel for studying the expression pattern of the raft marker proteins.  
2.3.4 Western blot  
  Type II cells, freshly isolated or cultured on plastic dishes for 3 and 7 days, MLE-
12 cells, and L2 cells were lysed in the lysis buffer (50 mM Tris-HCl , pH 7.4, 150 mM 
NaCl, 1% Triton X-100, 5 mM EGTA, 1 mM PMSF, 10 µg/ml aprotonin, 10 µg/ml 
leupeptin, and 1 mM benzamidine). Lung tissue was homogenized in the lysis buffer. 
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Lamellar bodies (LB) and plasma membrane (PM) were directly dissolved in the SDS 
sample buffer. Proteins were separated on SDS-PAGE, transferred onto nitrocellulose 
membranes and immunoblotted with specific antibodies. The primary antibodies were 
used at the following dilutions, 1:250 for flotillin-1 and VAMP-2; 1:1000 for syntaxin 2, 
annexin A2, SNAP-23, Na+-K+ ATPase, NSF; and 1:5000 for flotillin-2 and α-SNAP. 
HRP-conjugated secondary antibodies were used at a 1:2500 dilution in all the cases. The 
protein bands were visualized with the ECL reagents. The protein bands were quantified 
using a Bio-Rad densitometric scanner (Hercules, CA). 
2.3.5 Immunohistochemistry  
The lungs from male Sprague-Dawley rats were perfused with 50 mM PBS (pH 
7.4) and then lavaged four times with 5 ml of normal saline. Lungs were fixed by 
infusing 5 ml of 4% paraformaldehyde into the lungs and kept immersed in the same 
solution at room temperature for overnight. Paraffin-embedded lungs were sectioned (2 
µm) and placed on glass slides (Fisher Scientific, Pittsburgh, PA). The slides were 
deparaffinized with xylene and rehydrated with graded alcohol and PBS. Antigen 
retrieval was done by boiling the slides with citrate buffer (10 mM disodium citrate, pH 
6.0, and 0.05% Tween-20) for 20 minutes. Immunohistochemistry was performed as 
previously described (18).   Goat anti-SP-C antibodies were used at a dilution of 1:50, 
whereas mouse anti-flotillin-1 and -2 at 1:100. Alexa 546-conjugated anti-goat and Alexa 
488-conjugated anti-mouse antibodies were used at 1:250 dilutions.  
2.3.6 Isolation of lipid rafts 
  Lipid rafts were isolated from alveolar type II cells according to the previously 
reported method (12). In brief, freshly isolated type II cells (25 – 30 × 106) were washed 
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twice with MEM and once with MBS buffer (25 mM MES and 150 mM NaCl, pH 6.5). 
The cell pellet was lysed in 700 µl of ice-cold lysis buffer (MBS with 1% Triton X-100, 5 
mM EGTA; 1 mM PMSF, 10 µg/ml aprotonin, 10 µg/ml leupeptin, and 1 mM 
benzamidine) for 45 minutes on ice. Six hundred µl of lysate was carefully mixed with an 
equal volume of 80% sucrose (w/v) and gently laid at the bottom of an ultracentrifuge 
tube. Later, 1200 µl, each of 30% and 5% sucrose were laid over the 40% sucrose 
gradient and centrifuged at 200,000 ×g for 16 hours. Seven fractions were collected from 
top to bottom as follows: first two fractions of 600 µl each, followed by three fractions of 
400 µl each and two fractions of 600 µl each. Pellet was dissolved in 600 µl of lysis 
buffer and labeled as the eighth fraction. Equal volumes of each fraction were 
immunoblotted for various raft and non-raft marker proteins. For studying the effects of 
cholesterol depletion on lipid raft association of SNARE proteins, type II cells were 
solubilised in MBS containing Saponin (0.5% w/v), 0.5% TX-100, and a cocktail of 
protease inhibitors. A similar procedure was used in PC12 cells (12). 
2.3.7 Fusion pore formation 
Alveolar type II cells were grown on coverslips overnight. After removal of the 
unattached cells and equilibration with fresh MEM for 30 minutes, amphiphilic dye FM1-
43 (4 µM) was added and incubated for 10 minutes (19). The cells were stimulated with a 
combination of secretagogues (0.1 µM phorbol 12-myristate 13-acetate, 100 µM ATP 
and 20 µM terbutaline) for indicated periods of time in the presence of the dye. The cells 
were rinsed with 50 mM ice-cold phosphate buffered saline (PBS) and fixed with 4% 
paraformaldehyde. Under these conditions, the signals were not lost although extensive 
washing resulted in the loss of the signals. Excess fixative was quenched with 50 mM 
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ammonium chloride solution in PBS for 5 minutes. The cells were later washed three 
times with PBS and mounted onto the slides using mounting solution (1.5 % w/v n-
propyl gallate and 60% v/v glycerol in PBS). The positively stained lamellar bodies were 
counted in 50 cells selected at random under oil immersion (100X). Cholesterol depletion 
from alveolar type II cells was done by incubating the cells with media containing 3 mM 
methyl β-cyclodextrin (MCD) for about 30 minutes at 370C. The control cells were 
treated the same with MCD-cholesterol complex (40 μg cholesterol and 0.5% (w/v) or 
3.78 mM MCD). The cells were washed to remove MCD and incubated with fresh media 
for further studies. The extent of cholesterol depletion was assessed by cholesterol 
oxidase method (Amplex Red Cholesterol Assay Kit), as per the instructions of the 
manufacturer.  
To determine if cholesterol depletion affected lamellar body staining, overnight 
cultured type II cells were used. Following fixation, permeabilization and blocking for 
non-specific proteins, the cells were incubated with LB-180 antibodies (1:1000) for 
overnight. Later, they were incubated with Cy3-conjugated anti-mouse antibodies 
(1:250). Florescence was observed with Nikon Eclipse E600 Microscope. 
2.3.8 Membrane fusion  
  Lamellar bodies and plasma membrane were isolated from perfused rat lungs 
according to our previous protocols (7). The fusion of lamellar bodies with the plasma 
membrane was determined by the de-quenching of R18 as previously described (7).  R18-
labeled plasma membrane (5 μg protein) was incubated with lamellar bodies (10 μg 
protein) in 1 ml of Ca2+-EGTA buffer (40 mM Hepes, pH 7.0, 100 mM KCl, 1 mM 
EGTA, 1 mM Ca2+ free Ca2+) at 37oC for 2 min. The purified annexin A2 tetramer was 
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added to initiate the fusion. Fluorescence was monitored at Ex = 560 nm and Em=590 
nm. Fusion was expressed as a percentage of the maximal fluorescence (in the presence 
of 0.1% Triton X-100). 
2.3.9 Surfactant secretion from type II cells 
Isolated alveolar type II cells were pre-labeled with 0.6 µCi of [3H] choline and 
grown in 35 mm2 cell culture dishes. After overnight culture, unattached cells were 
removed by washing cells with warm MEM and then incubated in fresh media for 30 
minutes. The cells were stimulated with 0.1 µM phorbol 12-myristate 13-acetate, 100 µM 
ATP and 20 µM terbutaline for 2 hrs. Surfactant secretion assay was done as previously 
described (6). For cholesterol depletion, cells were incubated with 3 mM MCD for 30 
minutes before the stimulation. 
2.3.10 Raft Clustering 
  CD44 cross-linking was done as described (20). In brief, freshly isolated type II 
cells were washed three times with MEM. The cells were equilibrated in MEM, 
supplemented with 1 mM MgCl2 and 1 mM CaCl2, at 370C for 30 minutes. For cross-
linking, the cells were incubated with mouse anti-CD44 antibodies (20 µg/ml) for 60 
minutes, followed by incubation with Alexa-488-conjugated anti-mouse antibodies (20 
µg/ml) for another 60 minutes. The reaction was stopped by adding ice cold PBS. The 
cells were fixed with 4% paraformaldehyde and cytospun onto glass slides. The control 
type II cells were incubated with mouse anti-CD44 antibodies and then fixed, followed 
by the incubation with the secondary antibodies (see below). For cholesterol depletion, 
the cells were treated with 3 mM MCD for 30 minutes, washed three times with MEM, 
and cross-linked as described above. 
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For the double-labeling with CD44 and SNARE or annexin A2 antibodies, the 
slides above were washed with PBS and then permeabilised with 0.5% (v/v) Triton X-
100 for 30 minutes. The fixed cells were incubated with 10% (w/v) FBS and 1% (w/v) 
BSA for blocking non-specific binding. The cells were incubated with rabbit anti-annexin 
A2, syntaxin 2, or SNAP-23 antibodies at 1:100, 1:50, and 1:100 dilutions, respectively at 
40C overnight. The slides were washed and incubated with Alexa-488-conjugated anti-
mouse antibodies (20 μg/ml, for control non-cross-linking cells only) and Alexa-546-
conjugated anti-rabbit antibodies at 1:250 dilutions.  The cells were examined with a 
Leica confocal laser scanning fluorescent microscope. 
2.3.11 Protein Concentration Assay  
  Total protein concentration in cell lysates was determined by the Dc method 
(BioRad), and the protein concentration in each fraction of sucrose gradients was 
measured by the Bradford assay (BioRad). 
2.3.12 MTT assay  
  Overnight grown type II cells (1.5 ×106) in 35 mm dishes were used for the assay. 
The cells were treated with different concentrations of MCD for 30 minutes at 370C. 
Next, cells were washed with 50 mM PBS and incubated with 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT, 0.5 mg/ml) for 2 hours at 370C. Later, 
formazan crystals were dissolved in 2 ml of dimethyl sulfoxide by shaking the dishes for 
10 minutes. Absorbance was measured at 570 nm. The results were expressed as a 
percentage of the untreated control cells. 
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2.3.13 Statistical analysis  
 All the experiments were repeated atleast with 3 independent biological samples. 
Statistical significance was considered only when the p ≤ 0.05.  Student t test was used to 
compare the significant differences between the the control and treatment groups.  
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2.4 Results 
2.4.1 Identification of raft marker proteins  
Previous studies have reported the presence of lipid raft marker proteins in lung 
tissue (21,22). However, it is unclear whether these markers exist in alveolar type II cells. 
RT-PCR was performed to assess the presence of mRNA of various lipid raft markers in 
these cells, including caveolin-1α, -1β, -2, and -3, and flotillin-1 and -2.  Our results 
indicated that flotillin-1 and -2 mRNAs were expressed in both type II cells and lung 
tissue, whereas caveolin-1α, -1β, -2, and -3 mRNAs were only expressed in lung tissue, 
but not in type II cells (Fig. II. 1A). Western blotting revealed that flotillin-1 and -2 
proteins were expressed in freshly isolated type II cells (Fig. II. 1B). However, flotillin-1 
and -2 protein expression decreased when type II cells were cultured on plastic dishes, in 
which type II cells were known to trans-differentiate into the cells with some type I cell 
characteristics. Furthermore, both flotillin-1 and -2 were highly enriched in lamellar 
bodies fractions and plasma membrane fractions. They were also expressed in two lung 
epithelial cell lines: MLE-12 (mouse) and L2 (rat). Double-labeling with anti-SP-C 
(alveolar type II cell marker) and anti-flotillin-1 and -2 on rat lung tissue revealed that 
both flotillins were specifically localized in alveolar type II cells, but expression was 
minimal or low in type I cells (Fig. II. 1C). The controls without primary antibodies did 
not show labeling (data not shown).   
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Fig.  II. 1.   Identification of lipid raft markers in alveolar type II cells. (A) RT-PCR: 
The mRNAs extracted from freshly isolated alveolar type II cells (> 96% purity, T2) and 
whole lung tissue (L) were reverse-transcribed and amplified for 35 cycles with gene 
specific primers against caveolin (Cav) 1α, 1β, 2 and 3, flotillin (Flot) 1 and 2, and 18S 
rRNA. PCR products were electrophoretically separated on an agarose gel. MW: 100 bp 
DNA ladder. (B) Western blot: Freshly isolated type II cells (D0),  3 or 7 day-cultured 
type II cells on plastic dishes (D3 and D7), lung epithelial cell lines, MLE-12 and L2 
cells, along with lung homogenate (LH), purified plasma membrane (PM) and lamellar 
bodies (LB), were either lysed and/or solubilised in SDS sample buffer. Equal amounts of 
total protein (20 µg) were separated by SDS-PAGE and immunoblotted using anti-
flotillin-1 and -2 antibodies.  (C) Immunohistochemistry: Lung tissue sections were 
permeabilised and blocked before being incubated with goat-anti-SP-C and mouse anti-
flotillin- 1 and -2 antibodies. They were then incubated with donkey anti-goat Alexa-546-
conjugated and rabbit anti-mouse Alexa-488-conjugated antibodies. The slides were 
Phase contrast SP-C Flotillin-1 Merged
Bright Field Flotillin-2 Merged 
C 
Phase contrast SP-C Flotillin-2 Merged
 37
observed for immunoflorescence. Upper panels: double labeling with anti-flotillin-1 and 
SP-C antibodies; Lower panels: double labeling with anti-flotillin-2 and SP-C antibodies. 
Shown in the inset is the magnified image (100 ×) of a single type II cell. Scale bar: 20 
µm. 
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2.4.2 SNARE protein association with lipid rafts 
Lipid rafts are characterized by their resistance to non-ionic detergent 
solubilization and flotation when subjected to a discontinuous sucrose gradient 
centrifugation. Additionally, they are highly enriched in cholesterol.  We solubilized type 
II cells in ice-cold 1% (w/v) Triton X-100 and subjected the lysate to a gradient 
centrifugation. A white flocculent band was visible at the interface of 5 and 30% sucrose 
gradients. Seven fractions, collected from top to bottom (fractions 1 through 7), and the 
pellet (fraction 8), dissolved in lysis buffer, were analyzed for the contents of total 
proteins and cholesterol. Fraction 3 contained only 0.79 ± 0.15% of total protein, but 
22.30 ± 4.76% of total cholesterol (Fig. II. 2A and B). In contrast, soluble fractions 
(fractions 6 and 7) contained significant amount of total proteins (29.44 ± 2.74 and 38.94 
± 1.79% respectively), but a relatively small amount of cholesterol (21.43 ± 1.1 and 
12.56 ± 2.23% of total cholesterol, respectively). Each of the fractions was also screened 
for the presence of the lipid raft markers, flotillin-1 and –2, and the non-lipid raft marker, 
Na+-K+ ATPase. The results showed that fraction 3 was enriched in flotillin-1 and -2, 
whereas Na+-K+ ATPase was confined to the soluble fractions 6 and 7 (Fig. II. 2C). Thus, 
fraction 3 was confirmed to be the detergent insoluble and cholesterol-rich raft fraction. 
We further quantified the data by calculating the enrichment. A ratio of the flotillin band 
density and total protein in fraction 3 was first obtained. Similarly, a ratio of flotillin band 
densities in all the fractions and total protein in all the fractions was obtained. The first 
value was divided with the second to arrive at enrichment for flotillin. The data revealed 
that flotillin-1 and -2 were enriched by 42.66 ± 2.00 and 28.76 ± 9.09 fold (n=3) in the 
raft fraction. To study the effect of cholesterol sequestration on the lipid raft integrity, we 
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depleted cholesterol from type II cells using saponin (0.5% w/v) and 0.5% TX-100 in 
lysis buffer according to a reported procedure (12). In this case, cholesterol content in 
fraction 3 was reduced by approximately 75%. A major portion of flotillin-1 and -2 
shifted from raft (fraction 3) to non-raft fraction (Fig. II. 2C).  
 To examine the association of SNARE proteins with the lipid rafts of type II cells, 
an equal volume of each fraction was immunoblotted for the presence of major SNARE 
isoforms in type II cells: SNAP-23, syntaxin 2, and VAMP-2. Both t-SNAREs were 
present in the rafts, but SNAP-23 was highly enriched (24.12 ± 4.80 fold, n=3) in lipid 
rafts in comparison with syntaxin 2 (11.80 ± 3.73 fold, n=3) (Fig. II. 2C). On the other 
hand, VAMP-2, a v-SNARE, was moderately enriched (17.73 ± 4.45 fold, n=3) in lipid 
rafts. Other two SNARE regulatory proteins: α-SNAP and NSF were not found in the raft 
fraction of type II cells (data not shown).  When type II cells were solubilized in 0.5% 
saponin and 0.5% TX-100, the amount of SNARE proteins associated with the raft 
fraction was markedly decreased. The results indicated a genuine association of SNARE 
proteins with the lipid rafts.  
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Fig. II. 2. Effect of cholesterol depletion on SNARE protein association with lipid 
rafts. (A, B) Isolation of lipid rafts from alveolar type II cells: Lipid rafts were isolated 
from freshly isolated type II cells based on their detergent insolubility in 1% (w/v) Triton 
X-100 flotation on sucrose gradients. Seven fractions (1-7) were collected from top to 
bottom and the pellet solubilized in lysis buffer (fraction 8). Protein (A) and cholesterol 
(B) were measured in each of the fractions before and after cholesterol depletion (0.5% 
Triton X-100 and 0.5%, w/v Saponin). The results were expressed as a percent of total 
protein and cholesterol, respectively. Data shown are means ± S.E. (n=3).  Diamonds: 1% 
Triton X-100, circles:  0.5% Triton X-100 and 0.5% Saponin. (C)  SNARE association 
with lipid rafts: Type II cells were lysed in either 1% Triton X-100 (control) or 0.5% 
Triton X-100 and 0.5% saponin (cholesterol depletion) and subjected to raft isolation.  
Seven fractions were collected from top to bottoms. P: pellet. 5%, 30% and 40% 
 1     2      3       4      5       6      7      8   
P   5%   30%  40% 
Control 
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represent sucrose gradient. Each fraction was examined, by western blot, for the presence 
of the lipid raft marker proteins, flotillin-1 and -2, the non-lipid raft protein marker, Na+-
K+ ATPase, various SNARE proteins, SNAP-23, syntaxin 2 and VAMP-2. The 
immunublots shown are representatives of 3 independent experiments. 
 
Table. II. 1. Distrubution of in fractions following differential centrifugation (per 
cent of total) 
 
Fraction # Flotillin-1 Flotillin-2 Syntaxin-2 SNAP-23 VAMP-2 
1 3.42 ± 1.22 0.91 ± 0.33 1.90 ± 0.71 0.74 ± 0.39 6.29 ± 1.15 
2 4.00 ± 0.91 4.33 ± 2.28 2.58 ± 0.80 5.86 ± 1.98 7.31 ± 1.41 
3 32.87 ± 3.47 20.06 ± 2.06 9.10 ± 1.41 26.76 ± 2.76 14.13 ± 1.51
4 7.96 ± 1.74 7.21 ± 2.07 3.87 ± 0.80 10.51 ± 1.28 9.67 ± 1.46 
5 6.95 ± 1.33 7.85 ± 1.45 14.83 ± 2.75 14.52 ± 0.80 15.06 ± 0.88
6 9.96 ± 2.37 22.06 ± 2.68 25.81 ± 2.87 19.35 ± 0.40 20.35 ± 1.11
7 11.96 ± 1.46 21.23 ± 2.02 27.27 ± 3.25 19.96 ± 0.81 17.56 ± 1.48
8 22.45 ± 4.95 16.33 ± 1.70 15.34 ± 2.86 11.21 ± 2.09 9.32 ± 0.85 
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2.4.3 Effect of cholesterol depletion on fusion pore formation 
Having confirmed the association of SNARE proteins with the lipid rafts, we then 
questioned whether it has functional relevance to surfactant exocytosis in type II cells. To 
maintain the integrity of cell membrane and viability of the cells, MCD was used to 
deplete membrane cholesterol from type II cells. Cyclodextrins have been reported to 
specifically deplete membrane cholesterol (23). Incubation of type II cells with MCD for 
30 minutes at 37°C resulted in a dose-dependent decrease of cholesterol in type II cells 
(Fig. II. 3A). 3 mM MCD depleted 57 ± 6% of cholesterol without significantly affecting 
the cell viability (>90 %).  
During exocytosis, surfactant laden lamellar bodies fuse with the plasma 
membrane and release their contents via the fusion pore. The dynamics of surfactant 
release can be monitored for the formation of fusion pore using an amphiphilic dye, FM 
1-43 (19,24). The amphiphilic dye gains access to the lipids in the lamellar bodies 
through the fusion pore and stains the vesicular contents green. We sought to determine 
whether cholesterol depletion affects the fusion pore formation.  Type II cells were pre-
loaded for 10 minutes with FM1-43 (4 µM) and stimulated with a mixture of 
secretagogues. The formation of fusion pore was monitored by counting positively 
stained lamellar bodies. When the cells were cholesterol-depleted with 3 mM MCD, the 
fusion pore formation was completely inhibited. When the cells were treated with 
cholesterol-MCD complex, the fusion pore formation was unaffected (Fig. II. 3B, C). The 
effect of cholesterol depletion on the fusion pore formation is not due to the decrease in 
the number of lamellar bodies caused by MCD, because MCD does not affect the number 
of lamellar bodies as determined by staining type II cells with antibodies against a 
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lamellar body membrane protein, LB-180 (Fig. II. 3D). The number of positively stained 
lamellar bodies in the control and cholesterol-depleted cells was 25.92 ±1.42 and 24.56 
±1.37 per cell, respectively. 
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C. Quantification of fusion pore formation 
 
Condition Number of FM1-43 positive lamellar 
bodies/50 cells 
0-time 0.67 ± 0.67 
30 minute control 6.00 ± 6.00 
30 minute stimulation 346 ± 17.35 
MCD-0-time 0.00 
MCD-30 minutes 0.00 
MCD-30 minutes-stimulation 6.08 ± 6.00 
MCD-Cholesterol-0-time 0.00 
MCD-Cholesterol-30 minutes 0.00 
MCD-Cholesterol-30 minutes-stimulation 362 ± 13.57 
 
 
 
 
 
 
 
 
 
 47
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Control                        Depleted
Phase contrast 
LB-180 
D 
 48
Fig. II. 3. Cholesterol depletion inhibits the fusion pore formation in type II cells. 
(A) Cholesterol concentration and viability: Overnight cultured type II cells were treated 
with different concentrations of methyl-β-cyclodextrin (MCD) and the total cholesterol 
concentration and cell viability were measured using the Amplex red cholesterol assay kit 
and MTT assay, respectively. The results were expressed as percentage of control. Data 
shown are means ± SE from 3 independent cell preparations. Square: cholesterol, 
Diamond: cell viability. (B) Fusion pore formation: The overnight cultured cells were 
treated with 3 mM MCD or MCD-cholesterol complex (MCD-chol) and stimulated (sti) 
with secretagogues (0.1 mM ATP, 0.1 µM PMA and 20 µM terbutaline) for 30 min. The 
fusion pore formation was monitored by FM1-43 fluorescence. Upper panel, FM1-43 
staining; lower panel, phase contrast. (C) Quantification. The fusion pore formation was 
expressed as the number of the FM1-43-positive lamellar bodies per 50 cells. The results 
shown are means ± SE (n=3 independent cell preparations). (D) Effect of cholesterol 
depletion on the quality of lamellar bodies. Overnight cultured type II cells were treated 
with 3 mM MCD. The number of lamellar bodies was monitored by staining the cells 
with antibodies against a lamellar body membrane protein, LB-180.  
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2.4.4 Effect of cholesterol depletion on membrane fusion 
 We have previously shown that annexin A2 promotes the fusion of lamellar 
bodies with the plasma membrane using an in vitro assay (7). Using this assay, we 
determined whether the depletion of cholesterol affects the membrane fusion. The 
incubation of the isolated plasma membrane with MCD resulted in a dose-dependent 
reduction of cholesterol in the plasma membrane preparation (Fig. II. 4A). Three mM 
MCD depleted ∼ 50% of cholesterol from the plasma membrane. Under this condition, 
annexin A2-mediated fusion of lamellar bodies with the cholesterol-depleted plasma 
membrane was significantly decreased (Fig. II. 4B and C). The controls without the 
addition of annexin A2 did not show fusion for the untreated or cholesterol-depleted 
plasma membrane. 
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Fig. II. 4. Cholesterol depletion alters membrane fusion activity.  (A) Plasma 
membranes isolated from lung tissue were treated with different concentrations of MCD 
for 30 min at 37oC. Cholesterol content was assayed and the results expressed as a 
percentage of control. Data shown are means ± SE (n=3). (B, C) 5 µg/ml of control or 
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cholesterol-depleted plasma membranes (3 mM MCD) were mixed with 10 µg/ml of 
lamellar bodies in 1 ml of 1 mM Ca2+-EGTA buffer and membrane fusion was initiated 
by addition of 10 µg annexin A2 tetramer. The basal fusion was without the addition of 
annexin A2 teramer. B illustrates fusion curve as a function of time and C the fusion 
content at 6 minutes after the addition of annexin A2 (means ± SE, n=3). *P<0.05 v.s 
control. 
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2.4.5 Effect of cholesterol depletion on surfactant secretion by type II cells 
We also examined the effects of cholesterol depletion on surfactant secretion. As 
shown in Fig. II. 5, the secretion of lung surfactant was stimulated 4 fold by 
secretagogues. 3 mM MCD reduced the stimulated surfactant secretion by 69%. MCD 
also reduced the basal secretion, but did not reach a significant level. 
 
 
 
 
 
 
 
 
 
 
Fig. II. 5. Effect of cholesterol depletion on surfactant secretion. Overnight cultured 
type II cells were treated with 3 mM MCD for 30 min and then incubated without (basal) 
and with 0.1 mM ATP, 0.1 µM PMA, and 20 µM terbutaline for 2 hours (stimulated). 
Surfactant secretion was assayed. *P <0.05 vs no MCD treatment (Student t test, n=3) 
White bars, -MCD, Shaded bars, +MCD. 
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2.4.6 Co-localization of SNARE proteins with raft clusters 
The characteristic feature of rafts is their clustering upon cross-linking the raft-
associated proteins. The clusters, thus, aggregate the different protein associated with 
them and might represent the sites for protein interactions. CD44 is a transmembrane cell 
surface glycoprotein expressed by type II cells. We cross-linked CD44 proteins using 
anti-CD44 and secondary antibodies to determine whether SNARE proteins were 
recruited to rafts clusters. Both control and cross-linked cells were counterstained with 
anti-syntaxin 2 or SNAP-23. In the control cells, CD44, syntaxin 2, and SNAP-23 stained 
the plasma membrane, and cholesterol depletion did not change the distribution of these 
proteins (Fig. II. 6A and B). However, in the cross-linking cells, CD44 formed clusters or 
patches. Syntaxin 2 and SNAP-23 co-localized with the CD44 clusters, suggesting that 
syntaxin 2 and SNAP-23 may reside in the same lipid rafts. Efforts to further test this 
idea by disrupting rafts using 3 mM MCD were equivocal. Incomplete reduction in 
cluster formation and loss of CD44 florescence was observed owing to a 50-60% 
decrease in cholesterol content under our conditions. However, reasons for the loss of 
CD44 staining are unknown.  
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Fig. II. 6. SNARE proteins co-localize with raft clusters: Cells shown in the top two 
rows were fixed with 4% (w/v) paraformadehyde after exposure to mouse anti-CD44 but 
before exposure to anti-mouse IgG antibody. Cells shown in the bottom row were not 
fixed until after exposure to ant-mouse IgG antibody. Cells were double-labeled with 
anti-CD44 and anti-syntaxin 2 (A) or anti-SNAP-23 (B) antibodies. Images were taken 
with a confocal fluorescence microscope. 
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2.4.7 Annexin A2 and raft clustering 
Our previous reports have indicated that annexin A2 plays an important role in 
surfactant secretion (6,7). We investigated whether annexin A2 is associated with the 
lipid rafts of type II cells. Since annexin A2 binds to phospholipids in a Ca2+-dependent 
manner, we included 200 µM Ca2+ in the lysis buffer and subjected the type II cell lystate 
to the raft isolation. We found that annexin A2 was enriched in the raft fraction by 38-
fold in the presence of Ca2+ (Fig. II. 7A). There was no association of annexin A2 with 
lipid raft in the absence of Ca2+.  We further cross-linked CD44 proteins to see whether 
annexin A2 was recruited to rafts clusters. In the control cells, annexin A2 stained the 
plasma membrane (Fig. II. 7B). In the cross-linking cells, a co-localization of annexin A2 
with CD44 in the patches was evident, suggesting that annexin A2 was recruited to the 
raft clusters at the cytosolic side. 
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Fig. II. 7. Annexin A2 co-localizes with the lipid raft clusters. (A) Association of 
annexin A2 with the lipid rafts: Freshly isolated type II cells were lysed with 1% Triton 
X-100 in the presence or absence of 200 µM Ca2+, and separated on sucrose gradients. 
Seven fractions were collected from top to bottoms. P: pellet. 5%, 30% and 40% 
represent sucrose gradients. Each fraction was immunoblotted for annexin A2. (B) Raft 
clustering: CD44 clustering was done as described earlier. Cells were double-labeled with 
anti-CD44 and anti-annexin A2 antibodies. Images were taken with a confocal 
fluorescence microscope. 
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2.5 Discussion 
Exocytosis is an orderly process involving the interaction of highly conserved and 
diverse classes of proteins, resulting in the fusion between two opposing membranes. 
Lung surfactant secretion by type II cells is a highly regulated process. SNAREs and 
annexin A2 have been implicated in surfactant secretion. Our present studies 
demonstrated that SNARE proteins were associated with the lipid rafts of type II cells 
and that lipid raft integrity was essential for this association as well as fusion pore 
formation, membrane fusion, and lung surfactant secretion. The cross-linking of a 
transmembrane glycoprotein, CD44, using antibodies caused raft clustering and the 
recruitment of SNAREs and annexin A2 into these raft clusters.  These results suggested 
that lipid rafts may organize the exocytotic proteins on the membrane, and raft clusters 
may provide the docking and fusion sites for exocytosis. 
Earlier studies have shown that caveolin and flotillins were highly expressed in 
lung tissue (21,22,25,26). Caveolin-1 protein was detected in both alveolar epithelial type 
I and type II cells, but distinct plasma membrane invaginations were not observed in type 
II cells (25-27). However, we were not able to detect caveolins 1-4 in the freshly isolated 
type II cells by RT-PCR although their mRNAs expression were observed in lung tissue 
under the same conditions. The reasons for the contrary results are not clear. Both mRNA 
and protein expression of flotillin-1 and –2 were present in type II cells. 
Immunohistochemistry confirmed their specific localization in type II cells, but not type I 
cells. Flotillin-1 and -2 protein expression in the type II cells cultured on plastic dishes 
was decreased. A similar expression pattern for flotillin was reported when PC12 cells 
were cultured in vitro (28). Expression pattern of flotillins and caveolins in type I and II 
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cells might reflect the specific roles of these proteins in different cells, although there are 
a number of cells expressing both caveolins and flotillins, such as skate erythrocytes (29) 
and neonatal rat cardiomyocytes (30). Additionally, flotillin-1 and -2 were enriched on 
the plasma membrane and lamellar bodies, indicating their possible roles in membrane 
trafficking. 
Lipid rafts offer an interacting platform for many proteins involved in signal 
transduction and membrane trafficking, apart from being involved in protein sorting in a 
number of cells. Based on cellular fractionation and biochemical analysis, SNARE 
proteins were observed to be enriched in the lipid rafts of alveolar type II cells. This is 
also supported by the co-localization of SNAP-23 and syntaxin 2 with raft clusters upon 
cross-linking of a raft-associated cell surface protein CD44. The extent of enrichment for 
SNAP-23 was higher than its cognate t-SNARE partner, syntaxin 2, and v-SNARE 
protein, VAMP-2. Similar results were observed in other cells (12,14). The enrichment of 
SNAP-23 might be attributed to the palmitoylation at multiple cysteine residues.  Most 
recently, it has been reported that SNAP-23 was enriched to a higher extent than SNAP-
25 in PC12 cells, due to the substitution of phenyl alanine residue in SNAP-25 with a 
cysteine residue in SNAP-23 (31). However, the mechanism for the association of 
syntaxin 2/VAMP-2 with lipid rafts of type II cells is unknown.  Most syntaxin isoforms 
were associated with lipid rafts to various degrees depending on cell type and isoform 
(12,32,33). However, one report showed that syntaxin 2 was excluded from the lipid rafts 
in mast cells (14). When reconstituted into simple artificial membrane (liposome) 
containing phospholipids, cholesterol and spingomyelin, syntaxin 1A and VAMP-2 
preferred liquid-disordered domains (non-raft phase) (15), even though syntaxin 1A was 
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able to bind to cholesterol (13). Although the role of other lipid factors, such as 
phosphatidylinositol-4,5-bisphosphate in the targeting of syntaxin to lipid rafts can not be 
ruled out (34), it appeared that additional intrinsic factors and/or protein-protein 
interactions were required for the association of syntaxin and VAMP with lipid rafts in 
biological membranes. For example, SNAP-23 might bring syntaxin 2 into the rafts via 
the formation of a heterodimer since syntaxin and SNAP-23/25 were observed to form 
dimers, which may act as a docking site for VAMP-2, ultimately leading to the formation 
of a ternary SNARE complex (35).  Also, the cleavage of SNAP-25 by botulinum 
neurotoxin E disrupted syntaxin 1-SNAP-25 dimer and its co-localization in defined 
clusters (36). There was a significant amount of SNAREs present in non-raft fraction. 
Since lipid rafts are dynamic structures, it is likely that SNAREs can move in and out of 
lipid rafts, depending on the cell status and the physiological response. 
When type II cells were treated with MCD, cellular cholesterol content was 
reduced to ∼50-60%. Under the depleted conditions, the secretagogue-stimulated 
surfactant secretion decreased by ~70%. Since MCD can not enter the cells (23), it might 
deplete cholesterol on the plasma membrane without affecting intracellular membrane 
cholesterol. Thus, the actual reduction of cholesterol on the plasma membrane may be 
higher than 50%, which may account for a higher inhibition of surfactant secretion. The 
reduced secretion was probably not due to the decreased surfactant synthesis owing to the 
inability of MCD to permeate the cells or due to the depletion of lamellar bodies because 
MCD does not affect the number of lamellar bodies. Since SNARE proteins are enriched 
in lipid rafts and the lipid raft integrity depends on cholesterol, the reduced surfactant 
secretion by MCD is likely due to the disruption of lipid raft integrity and thus 
 62
disassembly of interacting platforms, provided by lipid rafts that are necessary for the 
SNARE complex formation.  
The size of lipid rafts is small (< 70 nm). Although cross-linking and fluorescence 
energy transfer (FRET) revealed their existence in living cells (37,38), lipid rafts are too 
small to function as docking and fusion sites. Individual rafts contain only a few numbers 
of proteins for protein-protein interactions to occur.  However, lipid rafts might aggregate 
or form clusters and act as the possible sites of exocytosis. Indeed, we observed that 
syntaxin 2 and SNAP-23 were co-localized with CD44 clusters. The mechanisms of lipid 
raft cluster formation in the cells are however unclear. One of the candidates that might 
play a role in this process is annexin A2. It was associated with lipid rafts in type II cells 
(Fig. 7) and other cells (39) in a Ca2+-dependent manner. The N-terminus of annexin A2 
is required for the association (40). The Ca2+-independent binding of annexin A2 to the 
membrane has also been reported (41), and this binding appears to depend on cholesterol 
(42,43). Similar to syntaxin 2 and SNAP-23, annexin A2 was recruited to raft clusters 
upon the cross-linking of CD44 (Fig. 7), suggesting role of annexin A2 in raft clustering 
and, thus, in the creation of docking and fusion sites in secretory cells. This conclusion is 
further supported by the following observations: (i) the infection of HeLa cells with 
enteropathogenic E. Coli induced actin-rich pedestals, clustering of raft clusters and 
recruitment of annexin A2 to such clusters (44); (ii) a trans-dominant mutant of annexin 
A2 comprising the N-terminal domain of annexin A2 and the N-terminus of p11 lead to 
the formation of large annexin A2 aggregates and co-clustering of the raft-associated 
protein, CD44 with the aggregates (20); and (iii) annexin A2 was found to be associated 
with nicotine-induced lipid rafts in chromaffin cells (45).  
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In summary, lipid rafts in type II cells may organize the SNARE protein 
machinery and their integrity is crucial for the fusion of lamellar bodies with the plasma 
membrane. 
2.6 Acknowledgements 
Contribution of co-cuthors: Dr. Nili Jin had done PC secretion experiments; Dr. 
Pengcheng Wang helped with membrane fusion assays; Dr. Telugu Akula Narasraju 
standardized conditions for CD44 clustering; Dr. Jiwang Chen did RT-PCR experiments.  
We thank Dr. Nicholas Cross for stimulating discussion and Ms. Candice Marsh for 
secretarial assistance. This work was supported by NIH R01 HL-052146 and R01 HL-
071628 (LL). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 64
2.7 References 
 
 1.  Sutton RB, Fasshauer D, Jahn R, Brunger AT. Crystal structure of a SNARE 
complex involved in synaptic exocytosis at 2.4 A resolution. Nature 1998;395:347-
353. 
 2.  Weber T, Zemelman BV, McNew JA, Westermann B, Gmachl M, Parlati F, Sollner 
TH, Rothman JE. SNAREpins: minimal machinery for membrane fusion. Cell 
1998; 92:759-772. 
 3.  Han X, Wang CT, Bai J, Chapman ER, Jackson MB. Transmembrane segments of 
syntaxin line the fusion pore of Ca2+-triggered exocytosis. Science 2004;304:289-
292. 
 4.  Abonyo BO, Wang P, Narasaraju TA, Rowan WH, III, McMillan DH, Zimmerman 
UJ, Liu L. Characterization of alpha-Soluble N-Ethylmaleimide-Sensitive Fusion 
Attachment Protein in Alveolar Type II Cells: Implications in Lung Surfactant 
Secretion. Am.J.Respir.Cell Mol.Biol 2003;29:273-282. 
 5.  Abonyo BO, Gou D, Wang P, Narasaraju T, Wang Z, Liu L. Syntaxin 2 and SNAP-
23 are required for regulated surfactant secretion. Biochemistry 2004;43:3499-3506. 
 6.  Liu L, Wang M, Fisher AB, Zimmerman UJP. Involvement of annexin II in 
exocytosis of lamellar bodies from alveolar epithelial type II cells. Am.J.Physiol 
1996;270:L668-L676. 
 7.  Chattopadhyay S, Sun P, Wang P, Abonyo B, Cross NL, Liu L. Fusion of lamellar 
body with plasma membrane is driven by the dual action of annexin II tetramer and 
arachidonic acid. J.Biol.Chem 2003;278:39675-39683. 
 8.  Gou D, Wang P, Jin N, Liu L. Silencing of annexin II in primary culture of alveolar 
epithelial type II cells. Annexins 2004;1:31-36. 
 9.  Rajendran L, Simons K. Lipid rafts and membrane dynamics. J.Cell Sci 
2005;118:1099-1102. 
 10.  Brown DA, London E. Functions of lipid rafts in biological membranes. 
Annu.Rev.Cell Dev.Biol 1998;14:111-136. 
 11.  Lafont F, Verkade P, Galli T, Wimmer C, Louvard D, Simons K. Raft association 
of SNAP receptors acting in apical trafficking in Madin-Darby canine kidney cells. 
Proc.Natl.Acad.Sci.U.S.A 1999;96:3734-3738. 
 12.  Chamberlain LH, Burgoyne RD, Gould GW. SNARE proteins are highly enriched 
in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. 
Proc.Natl.Acad.Sci.U.S.A 2001;98:5619-5624. 
 65
 13.  Lang T, Bruns D, Wenzel D, Riedel D, Holroyd P, Thiele C, Jahn R. SNAREs are 
concentrated in cholesterol-dependent clusters that define docking and fusion sites 
for exocytosis. EMBO J 2001;20:2202-2213. 
 14.  Pombo I, Rivera J, Blank U. Munc18-2/syntaxin3 complexes are spatially separated 
from syntaxin3-containing SNARE complexes. FEBS Lett 2003;550:144-148. 
 15.  Bacia K, Schuette CG, Kahya N, Jahn R, Schwille P. SNAREs prefer liquid-
disordered over "raft" (liquid-ordered) domains when reconstituted into giant 
unilamellar vesicles. J.Biol.Chem  2004;279:37951-37955. 
 16.  Dobbs LG, Gonzalez R, Williams MC. An improved method for isolating type II 
cells in high yield and purity. Am.Rev.Respir.Dis  1986;134:141-145. 
 17.  Chen JW, Chen Z, Narasaraju T, Jin N, Liu L. Isolation of hightly pure alveolar 
epithelial type I and type II cells from rat lungs. Lab Invest 2004;84:727-735. 
 18.  Narasaraju TA, Jin N, Narendranath CR, Chen Z, Gou D, Liu L. Protein nitration in 
rat lungs during hyperoxia exposure: a possible role of myeloperoxidase. 
Am.J.Physiol Lung Cell Mol.Physiol 2003;285:L1037-L1045. 
 19.  Bates SR, Tao JQ, Notarfrancesco K, DeBolt K, Shuman H, Fisher AB. Effect of 
Surfactant Protein-A on Granular Pneumocyte Surfactant Secretion in Vitro. 
Am.J.Physiol Lung Cell Mol.Physiol 2003;285:L1055-L1065. 
 20.  Oliferenko S, Paiha K, Harder T, Gerke V, Schwarzler C, Schwarz H, Beug H, 
Gunthert U, Huber LA. Analysis of CD44-containing lipid rafts: Recruitment of 
annexin II and stabilization by the actin cytoskeleton. J.Cell Biol 1999;146:843-
854. 
 21.  Nanjundan M, Possmayer F. Pulmonary lipid phosphate phosphohydrolase in 
plasma membrane signalling platforms. Biochem.J 2001;358:637-646. 
 22.  Palestini P, Calvi C, Conforti E, Daffara R, Botto L, Miserocchi G. Compositional 
changes in lipid microdomains of air-blood barrier plasma membranes in 
pulmonary interstitial edema. J.Appl.Physiol 2003;95:1446-1452. 
 23.  Neufeld EB, Cooney AM, Pitha J, Dawidowicz EA, Dwyer NK, Pentchev PG, 
Blanchette-Mackie EJ. Intracellular trafficking of cholesterol monitored with a 
cyclodextrin. J.Biol.Chem 1996;271:21604-21613. 
 24.  Haller T, Ortmayr J, Friedrich F, Volkl H, Dietl P. Dynamics of surfactant release 
in alveolar type II cells. Proc.Natl.Acad.Sci.U.S.A 1998;95:1579-1584. 
 25.  Campbell L, Hollins AJ, Al-Eid A, Newman GR, von Ruhland C, Gumbleton M. 
Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in 
lung alveolar epithelial primary cultures. Biochem Biophys Res Commun 
1999;262:744-751. 
 66
 26.  Newman GR, Campbell L, von Ruhland C, Jasani B, Gumbleton M. Caveolin and 
its cellular and subcellular immunolocalisation in lung alveolar epithelium: 
implications for alveolar epithelial type I cell function. Cell Tissue Res 
1999;295:111-120. 
 27.  Kolleck I, Guthmann F, Ladhoff AM, Tandon NN, Schlame M, Rustow B. Cellular 
cholesterol stimulates acute uptake of palmitate by redistribution of fatty acid 
translocase in type II pneumocytes. Biochemistry 2002;41:6369-6375. 
 28.  Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP. 
Flotillins/cavatellins are differentially expressed in cells and tissues and form a 
hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-
mapping of a novel flotillin-1 monoclonal antibody probe. J.Biol.Chem 
1999;274:12702-12709. 
 29.  Musch MW, Koomoa DL, Goldstein L. Hypotonicity-induced exocytosis of the 
skate anion exchanger skAE1: role of lipid raft regions. J.Biol.Chem 
2004;279:39447-39453. 
 30.  Rybin VO, Grabham PW, Elouardighi H, Steinberg SF. Caveolae-associated 
proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3. 
Am.J.Physiol Heart Circ.Physiol 2003;285:H325-H332. 
 31.  Salaun C, Gould GW, Chamberlain LH. The SNARE proteins SNAP-25 and 
SNAP-23 display different affinities for lipid rafts in PC12 cells. Regulation by 
distinct cysteine-rich domains. J.Biol.Chem 2005;280:1236-1240. 
 32.  Gil C, Soler-Jover A, Blasi J, Aguilera J. Synaptic proteins and SNARE complexes 
are localized in lipid rafts from rat brain synaptosomes. 
Biochem.Biophys.Res.Commun  2005;329:117-124. 
 33.  Xia F, Gao X, Kwan E, Lam PP, Chan L, Sy K, Sheu L, Wheeler MB, Gaisano HY, 
Tsushima RG. Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel 
gating and insulin exocytosis. J.Biol.Chem  2004;279:24685-24691. 
 34.  Aoyagi K, Sugaya T, !Lost Data, Yamamoto S, Terakawa S, Takahashi M. The 
activation of exocytotic sites by the formation of phosphatidylinositol-4,5-
bisphosphate microdomains at syntaxin clusters. J Biol.Chem 2005;280:17346-
17352. 
 35.  Hu K, Carroll J, Fedorovich S, Rickman C, Sukhodub A, Davletov B. Vesicular 
restriction of synaptobrevin suggests a role for calcium in membrane fusion. Nature 
2002;415:646-650. 
 36.  Rickman C, Meunier FA, Binz T, Davletov B. High affinity interaction of syntaxin 
and SNAP-25 on the plasma membrane is abolished by botulinum toxin E. J 
Biol.Chem 2004;279:644-651. 
 67
 37.  Friedrichson T, Kurzchalia TV. Microdomains of GPI-anchored proteins in living 
cells revealed by crosslinking. Nature 1998;394:802-805. 
 38.  Varma R, Mayor S. GPI-anchored proteins are organized in submicron domains at 
the cell surface. Nature 1998;394:798-801. 
 39.  Babiychuk EB, Draeger A. Annexins in cell membrane dynamics. Ca(2+)-regulated 
association of lipid microdomains. J.Cell Biol  2000;150:1113-1124. 
 40.  Babiychuk EB, Monastyrskaya K, Burkhard FC, Wray S, Draeger A. Modulating 
signaling events in smooth muscle: cleavage of annexin 2 abolishes its binding to 
lipid rafts. FASEB J  2002;16:1177-1184. 
 41.  Liu L, Tao JQ, Zimmerman UJP. Annexin II binds to the membrane of A549 cells 
in a calcium-dependent and calcium-independent manner. Cell.Signal 1997;9:299-
364. 
 42.  Harder T, Kellner R, Parton RG, Gruenberg J. Specific release of membrane-bound 
annexin II and cortical cytoskeletal elements by sequestration of membrane 
cholesterol. Mol.Biol.Cell 1997;8:533-545. 
 43.  Ayala-Sanmartin J, Henry JP, Pradel LA. Cholesterol regulates membrane binding 
and aggregation by annexin 2 at submicromolar Ca(2+) concentration. 
Biochim.Biophys.Acta 2001;1510:18-28. 
 44.  Zobiack N, Rescher U, Laarmann S, Michgehl S, Schmidt MA, Gerke V. Cell-
surface attachment of pedestal-forming enteropathogenic E. coli induces a 
clustering of raft components and a recruitment of annexin 2. J.Cell Sci 
2002;115:91-98. 
 45.  Chasserot-Golaz S, Vitale N, Umbrecht-Jenck E, Knight D, Gerke V, Bader MF. 
Annexin 2 Promotes the Formation of Lipid Microdomains Required for Calcium-
regulated Exocytosis of Dense-Core Vesicles. Mol.Biol.Cell 2005;16:1108-1119. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 68
CHAPTER III 
 
KNOCKDOWN OF FLOTILLIN-2 INHIBITS LUNG SURFACTANT SECRETION 
BY ALVEOLAR TYPE II CELLS 
 
 
 
3.1 Abstract 
 
 Lung surfactant secretion involves the fusion of lamellar bodies with the plasma 
membrane. Membrane rafts enriched with SNARE proteins are crucial for this process. 
We investigated the role of flotillins, membrane raft proteins, in this process by 
decreasing the expression of flotillin-1 and -2 by RNA interference. The reduction of 
flotillin-2 inhibited lung surfactant secretion, but it did not disrupt membrane rafts or the 
association of SNAREs with the rafts nor did it alter the cellular cholesterol level. We 
conclude that flotillin-2 is required for surfactant secretion but not via the association of 
SNAREs with the rafts or cholesterol homeostasis. 
 
Keywords: flotillin-2; lung surfactant; alveolar type II cells; lung; membrane fusion; 
exocytosis  
 
 
 
 
 
 
 69
3.2 Introduction 
 Lung surfactant is stored in lamellar bodies and exocytosed following fusion of 
the lamellar bodies with the plasma membrane of alveolar type 2 (type II) cells [1]. 
However, the secretion of surfactant is a much slower process when compared to 
neurotransmitter release, indicating that additional control mechanisms are needed for 
surfactant secretion. A number of proteins have been shown to be involved in surfactant 
secretion including SNAREs, NSF, α-SNAP and annexin A2 [2-5]. In addition, SNAP-
23, syntaxin-2 and VAMP-2 are enriched in type II cell membrane rafts. Cholesterol 
depletion has been shown to drastically reduce membrane fusion and surfactant secretion 
[6], indicating a role for membrane rafts in surfactant secretion. 
 Flotillins (or reggies) are evolutionarily conserved and ubiquitously expressed 
proteins in bacteria, yeast and eukaryotes. There are two isoforms, flotillin -1 (or reggie-
2) and flotillin-2 (or reggie-1). They are expressed in many cell types including type II 
cells [6]. Flotillins associate with membrane rafts owing to multiple palmitoylation at 
Cys-34 in the case of flotillin-1 and additional myristoylation at Gly-2 in the case of 
flotillin-2. Flotillin-1, but not flotillin-2, is also located in the nuclei of PC-3 cells, a 
human prostate cancer cell line [7]. The distribution of these proteins indicates that 
flotillin-1 and flotillin-2 may differ in their cellular functions. 
 Several functions of flotillins have been reported including interaction with actin, 
kinases and the cytoskeleton; formation of filopodia; insulin signaling; axonal 
regeneration and cell-cell contacts and membrane trafficking [8-10]. Overexpression of 
flotillins results in defects in the imaginal discs in the eyes and wings of Drosophila [11]. 
Other evidence shows that flotillin overexpression leads to the emergence of filopodia in 
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various epithelial cell lines [12]. Flotillins are highly expressed during certain stages of 
zebrafish embryonic development, and knockdown of flotillins by morpholino antisense 
oligonucleotides has been shown to cause brain defects in zebrafish embryos [11-13].  
 The evidence for a role of flotillins in exocytosis is lacking except for a recent 
study which indicates the participation of flotillin-1 in mast cell exocytosis [14]. In this 
study, we investigated the functional role of flotillins in relation to surfactant secretion in 
type II cells. 
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3.3 Materials and Methods 
3.3.1 Construction of adenoviral vectors: 
 The mouse U6 promoter was PCR-amplified with Pfu DNA polymerase from 
pSilencer 1.0 vector with upstream primer 1 (5’-
CACCGCGGATCGATCCGACGCCGCCATCTCTA-3’) and downstream primer 2 (5’-
GCTTCGAAGAATTCCCGGGTCTCTCAAACAAGGCTTTTCTCCAA-3’). Five 
restriction sites (Eco31I, SmaI, EcoRI, BstBI and BglII) were introduced at the 3-end of 
the mU6 promoter. After the double digestion with SacII and BglII restriction enzymes, 
the mU6 promoter was inserted into the pENTR/CMV-EGFP vector (Invitrogen, 
Carlsbad, CA) through corresponding sites as described earlier [15]. Later, the 
pENTR/mU6-CMV-EGFP vector was linearized with Bsa1 and BstBI restriction 
enzymes to facilitate directional cloning of the annealed shRNAs oligonucleotides with 
5`-TTTG and 5’-GC overhangs. We designed three siRNA sequences targeted to 
different regions of each gene using Web-based SiRNA Design Software 
(http://i.cs.hku.hk/~sirna/software/sirna.php). These siRNAs include 118-137, 522-540 
and 584-603 of flotillin-1 mRNA which were designated as F-1 shRNA (A), (B) and (C), 
respectively. Similarly, shRNAs, 53-73, 602-620 and 1163-1182 of flotillin-2 mRNA 
were named F-2 shRNA (A), (B) and (C), respectively. The annealed oligonucleotides 
with 5`-TTTG and 5’-GC overhangs were composed of a sense strand containing 19-21 
nucleotides, followed by a short spacer (5'-TTCAAGAGA-3'), an antisense strand and 
five thymidines. All the shRNA inserts subcloned into the pENTR/mU6-CMV-EGFP 
vector were verified by DNA sequencing. The shRNA and EGFP expression cassette in 
the pENTR vector were then switched into the adenoviral vector, pAd/PL-DEST, through 
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the Gateway technique, exactly as described by the vendor. The resulting adenoviral 
plasmids were linearized by PacI, purified by Phenol-chloroform, and then transfected 
into 293A cells with Lipofectamine 2000 for adenovirus generation. Later the viruses 
were further amplified in 293A cells. The titers of adenovirus were determined through 
the EGFP signal in 293A cells after one day post-infection with serial dilutions of the 
virus. 
3.3.2 Knockdown of flotillins in L2 cells 
 L2 cells, derived from rat lung epithelial cells, were used at 18-25 passages. The 
cells (1×105) were subcultured in 0.5 ml of F12K (Ham’s modification) supplemented 
with 10% FBS, non-essential amino acids and penicillin and streptomycin in 12-well cell 
culture plates. The cells were infected with various doses of adenoviruses with 
multiplicity of infection (MOI) units from 0-150 on the day of subculture. The media was 
changed after day 1 and day 3 of culture. At day 5, the cells were washed with ice-cold 
50 mM phosphate buffered saline (PBS) and lysed with lysis buffer [50 mM Tris (pH 
7.4); 150 mM NaCl; 1% (v/v) Triton X-100 and protease inhibitor cocktail]. Protein 
concentrations were determined using the Dc method (BioRad, Hercules, CA). The 
lysates were used for immunoblotting. 
3.3.3 Surfactant secretion 
 Type II cells were isolated as previously described [6]. The purity and viability of 
the cells were greater than 90% and 95%, respectively. Type II cells were cultured on 
collagen-matrigel matrix with air-liquid interface as reported earlier [16]. Surfactant 
secretion was assayed as previously described [4]. 
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3.3.4 Knockdown of flotillins in type II cells: 
 The cells were cultured and infected (100 MOI) as described earlier [17]. 
Following infection on day 2, the cells were further cultured for 5 more days on an air-
liquid interface. Cells were lysed at the end of 5 days of culture. Cell lysates were later 
probed for flotillin-1 and -2 to assess the level of knockdown. The blots were re-probed 
with anti-β-actin as a loading control. 
3.3.4 Isolation of membrane rafts 
 The protocol for isolation of L2 cell membrane rafts was similar to that from type 
II cells as previously described [6]. Adenovirus (100 MOI) was added at the day of 
subculture, and culture continued for 5 days. Later the cells were solubilized in ice-cold 
lysis buffer (MBS with 1% Triton X-100 and protease inhibitor cocktail) for 45 min. 
Equal amounts of total protein from control and siRNA-treated cells were then subjected 
to raft isolation using a discontinuous sucrose gradient centrifugation.  Fractions 1, 2, 3 
and 4 were collected from top to bottom of the gradients. The membrane pellet (fraction 
5) was re-suspended in lysis buffer. Membrane rafts (fraction 2) were enriched at the 
interface between the 5% and 30 % sucrose gradients.  Equal volumes of fractions were 
used for detecting flotillin-1, -2 and SNAREs by Western blot. 
3.3.5 Cholesterol content 
 Cholesterol content was determined using the Amplex Red Cholesterol assay kit 
(Invitrogen, Carlsbad, CA) according to the instructions of the manufacturer. 
2.3.6 Immunoblotting 
 Immunoblotting was done exactly as described earlier [6]. Proteins were 
separated on 10% SDS-PAGE and transferred onto nitrocellulose membranes. The 
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membranes were blocked with 5% non-fat skim milk and then incubated overnight with 
either anti-flotillin-1, anti-syntaxin-2, anti-SNAP-23 or anti-β-actin at a 1:1000 dilution 
or with anti-flotillin-2 or anti-GAPDH at a 1:5000 dilution. After washing, the 
membranes were incubated with HRP-conjugated goat anti-rabbit or goat anti-mouse 
antibodies at a 1:2500 dilution. Later, the proteins were visualized using ECL reagents 
and X-film. 
3.3.7 Cell Viability  
 Cell viability following adenovirus infection was ascertained by the MTT assay as 
described previously [6]. 
3.3.8 Statistical analysis  
 All the experiments were repeated atleast with 3 independent biological samples. 
Statistical significance was considered only when the p ≤ 0.05.  Student t test was used to 
compare the significant differences between the the control and treatment groups.  
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3.4 Results 
3.4.1 Knockdown of flotillins in L2 cells 
 
 Adenoviral vectors containing shRNA sequences are being extensively used for 
knockdown of protein owing to their high infection efficiency in cells, particularly 
primary cells. The adenoviral vectors used in the present study contained shRNA 
sequences under the control of the mouse U6 promoter and EGFP expression under the 
control of the CMV promoter. The siRNA sequences were targeted to different regions of 
flotillin-1 and -2. The construct with irrelevant sequences served as a virus control (VC). 
The cells which were not infected with any virus were used as blank controls (BC). The 
use of VC and BC enabled us to monitor any virus effects. 
L2 cells were used for screening the effective constructs. Our earlier studies have 
demonstrated the expression of flotillin-1 and -2 in L2 cells [6]. Our preliminary studies 
indicated that shRNA sequences targeted to flotillin-1 nucleotides 118-137 [F-1 shRNA 
(A)], but not to nucleotides 522-540 [F-1 shRNA (B)] or 584-603 [F-1 shRNA (C)] was 
effective in silencing the expression of flotillin-1 (data not shown). Therefore, this 
sequence was used for subsequent experiments. Infection efficiency was increased as the 
MOI of the virus increased as observed by the EGFP florescence (Fig. III. 1A). When the 
cells were infected with F-1 shRNA (A), a significant decrease in protein expression of 
flotillin-1 was observed. This effect was virus-dose dependent. A maximal depression of 
flotillin expression was seen at MOI ≥ 70 (Fig. III. 1B). The control virus had no effects 
on flotillin-1 expression. There was no statistically significant difference in cell viability 
in all the treatments (data not shown). 
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 Similar analysis was performed for the flotillin-2 knockdown. Preliminary results 
indicated that the siRNA sequences targeted to 1163-1182 [F-2 shRNA (C)] of flotillin-2 
were the most effective in silencing the flotillin-2 protein expression in comparison with 
53-73 [F-2 shRNA (A)] and 602-620 [F-2 shRNA (B)] (data not shown). Once again, 
virus dose-dependent infection efficiency was observed (Fig. III. 1D). The F-2 shRNA 
(C) decreased flotillin-2 protein expression and the control virus had no effects (Fig. III. 
1D). The F-2 shRNA (C) did not affect the cell viability (data not shown). 
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Figure III. 1. Knockdown of flotillin-1 and flotillin-2. L2 cells were infected with 
different doses (MOIs) of F-1 shRNA (A) adenovirus and cultured for 5 days. A) 
Infection efficiency. Shown are the representative EGFP fluorescence images, indicating 
the infection efficiency. B) Dose-dependent knockdown of flotillin-1. The flotillin-1 
protein level was determined by Western blot. Equal loading was confirmed by re-
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probing the membranes with anti-GAPDH antibodies. L2 cells were also infected with 
various doses MOIs of F-2 shRNA (C) adenovirus and cultured for 5 days. C) Infection 
efficiency. Shown are the representative EGFP florescence images. B) Dose-dependent 
knockdown of flotillin-2. The flotillin-2 protein level was determined by Western blot. 
BC: blank control, VC: virus control (MOI= 140).  
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3.4.2 Effect of flotillin silencing on surfactant secretion 
 The role of flotillins in surfactant secretion by type II cells was subsequently 
studied. To this end, type II cells were cultured on an air-liquid model and infected with 
adenovirus containing F-1 shRNAs and F-2 shRNAs. F-1 shRNA (A) almost completely 
silenced flotillin-1 expression (Fig. III. 2A). However, F-1 shRNA (A) also decreased 
flotillin-2 expression although a significant amount of flotillin-2 remained in the F-1 
shRNA (A)-treated type II cells (Fig. III. 2B). Among F-2 shRNAs, F-2 shRNA (C) was 
the most effective in silencing flotillin-2 expression. This shRNA also reduced flotillin-1 
expression (Fig. III. 2A and B), probably because the stability of flotillin-1 is dependent 
on flotillin-1 [11, 18]. Using F-1 shRNA (A) and F-2 shRNA (C), we determined the 
effect of flotillin-1 and -2 silencing on surfactant secretion. There were no statistically 
significant differences in the basal and stimulated secretions between control and F-1 
shRNA (A) - treated cells (Fig. III. 2C). However, F-2 shRNA (C) reduced stimulated 
surfactant secretion. The basal secretion appears to be decreased in the F-2 shRNA (C)-
treated cells but did not reach a significant level. The control virus had no effect on 
surfactant secretion. 
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Figure III. 2. Effect of flotillin silencing on surfactant secretion. Type II cells were 
infected with different shRNA adenovirus at an equal dose of 100 MOI and cultured for 5 
days. Equal amounts of proteins were immunoblotted for A) flotillin-1 and B) flotillin-2. 
The same membranes were re-probed for β-actin to confirm equal loading. C) Surfactant 
secretion. The control and flotillin knockdown cells were washed and equilibrated 30 min 
in serum-free medium (0-time). The cells were incubated 2.5 h in the absence (control) or 
presence of 100 μM ATP, 0.1 μM PMA and 10 μM terbutaline (stimulated). The results 
were expressed as means ± S.E. *P < 0.05 versus VC (Student t test n ≥ 3). BC: blank 
control, VC: virus control (MOI= 140). 
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3.4.3 Effect of flotillin silencing on raft formation 
 Earlier studies speculated a role of flotillins in the formation of membrane rafts 
[19]. We examined whether the loss of flotillin affects raft formation in lung cells. 
Because large amounts of cells were needed for this experiment, we used L2 cells rather 
than type II cells for this experiment. The control and flotillin knockdown L2 cells were 
subjected to raft isolation. Following raft isolation, various fractions were collected.  
Fraction 2 represents the raft fraction (the interface between 5% and 30% sucrose). Each 
fraction was analyzed for protein and cholesterol content. When compared with blank 
and virus controls, there were no obvious differences in the amounts of protein and 
cholesterol of the raft fractions between control and flotillin-1 or -2 knockdown cells 
(Fig. III. 3A and B). When cholesterol concentration was expressed as μg per μg protein, 
cholesterol content in the raft fraction (fraction 2) was enriched 3-, 10-, and 20- fold in 
comparison with fractions 3, 4, and 5 (data not shown).   
3.3.4 Effect of flotillin silencing on SNARE protein association with membrane rafts 
Membrane rafts have been implicated in exocytotic processes. SNARE proteins 
were differentially enriched in rafts in a number of cell types including type II cells [6, 
20]. We therefore examined whether knockdown of flotillin leads to dissociation of 
SNAREs with membrane rafts. Following silencing, little flotillin-1 and -2 proteins were 
detected in any of the fractions, indicating an effective silencing. When raft fractions 
(fraction 2) were probed for SNARE proteins following silencing, there was no change in 
the association of these proteins with membrane rafts (Fig. III. 3C and D). The results 
indicate that flotillin-1 and -2 were not involved in the association of syntaxin-2 and 
SNAP-23 in L2 cells. 
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Figure III. 3. Effect of flotillin silencing on membrane raft formation. A and B) Total 
protein content and total cholesterol content. Following flotillin-1 and -2 knock down 
with F-1shRNA (A) or F-2 shRNA (C) adenovirus (100 MOI), L2 cell lysates were 
subjected to raft isolation. Total protein A) and cholesterol content B) in each fraction 
were measured and expressed as a percentage of total protein or cholesterol in all 
fractions.  Following knockdown of flotillin-1 C) or -2 D) with F-1shRNA (A) or F-2 
shRNA (C) adenovirus (100 MOI), membrane rafts were isolated. Equal volumes of 
various fractions were probed for flotillin-1 or flotillin-2, SNAP-23 and syntaxin 2. BC: 
blank control, VC: virus control (MOI= 140).  Lanes 1-5 represent the respective 
fractions.     
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3.4.5 Effect of flotillin silencing on cholesterol content 
Membrane rafts are also reported to be involved in cholesterol homeostasis. We 
further investigated the effects of flotillin-1 and -2 silencing on cholesterol levels in L2 
cells. Following silencing of flotillin-1 and -2, cell lysates were analyzed for total 
cholesterol levels. Our results indicated that there were no statistical significant 
differences in cholesterol levels under silencing conditions when compared with controls 
(Fig. III. 4). 
 
 
 
Figure 4: Effect of flotillin silencing on cholesterol content. L2 cells were infected 
with F-1shRNA (A) or F-2 shRNA (C) adenovirus (100 MOI). Cholesterol levels were 
assayed and expressed as a percentage of BC. Blue bars, F-1 shRNA (A); Purple bars, F-
2 shRNA (C). Shown are means ± S.E. (n ≥ 3). BC: blank control. VC: virus control 
(MOI= 140). 
 
MOI
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3.5 Discussion 
 Flotillins are membrane-bound raft marker proteins involved in a number of 
functions including membrane trafficking. The present study investigated the role of 
these proteins in surfactant secretion. Our results indicated that silencing of one of the 
isoforms, flotillin-2, decreased surfactant secretion. 
Our results indicated that the flotillin-2 knockdown led to reduced expression of 
flotillin-1. Previous studies have demonstrated that the stability of flotillin-1 protein 
depends on the presence of flotillin-2 as the former undergoes proteosomal degradation in 
the absence of the latter [11, 18]. Similar results have been reported for other SPFH 
family proteins such as prohibitins, HflK and HflC [21, 22]. In the caveolin-1 knockout 
mice, the caveolin-2 level is decreased [23]. 
Flotillin-2, but not flotillin-1 knockdown, resulted in a reduced surfactant 
secretion. Similar to our results, flotillin-1 knockdown did not affect the mast cell 
degranulation following simulation with phorbol esters or the calcium ionophore, 
A23187. However, a reduction of flotillin-1 level decreased degranulation induced by 
FcεR cross-linking, indicating its role in IgE-mediated signaling [14]. 
Surfactant secretion by type II cells is a SNARE protein-dependent process and 
SNAREs are associated with membrane rafts [2, 3, 5, 6]. We hypothesized that flotillins 
may play a role in the SNARE association with membrane rafts. However, our results 
indicated that there were no changes in the pattern of SNARE association with membrane 
rafts in the absence of flotillin-1 or -2. Thus, SNARE protein association with rafts 
appears to be independent of flotillins. Previous studies reported that flotillin-2 did not 
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interfere with the targeting of Gαq, Cbp and Lyn kinase proteins to the membrane rafts, 
but regulated their activities [14, 24]. 
In the present study, we found that the formation of membrane rafts was not 
altered by the knockdown of flotillins as indicated by total cholesterol content and the 
amount of total protein in the raft fractions. This is consistent with the finding in RBL-
2H3 cells [14]. The loss of caveolin-1 disrupts the distinct plasma membrane 
invaginations, but does not affect the raft formation [23]. The detergent-resistant 
membrane rafts isolated by sucrose gradient centrifugation are extremely diverse and 
heterogeneous and are composed of several rafts with distinct raft markers [25, 26]. It is 
possible that the changes in a particular type of raft on lamellar bodies or plasma 
membrane due to the loss of flotillins can not be detected by the chosen biochemical 
analyses. 
In 3T3-L1 cells, flotillin-1 co-localized with LAMP-1 positive vesicles and in 
macrophages, thus implicating the protein in phagosome maturation [27-29]. Moreover, 
flotillin-1 was shown to interact with ABCA1, the main protein involved in cholesterol 
transport in human macrophages [30]. ABCA1 deficiency in mice resulted in altered 
surfactant metabolism [31]. Our previous study indicated an abundance of flotillins on 
lamellar bodies [6]. These findings prompted us to investigate cholesterol homeostasis 
following flotillin-1 and -2 knock down. However, we did not find any changes in total 
cellular cholesterol after flotillin-1 or -2 silencing. 
 In summary, flotillin-2 is required for surfactant secretion independent of 
SNARE association of membrane rafts. The mechanisms for flotillin-2-mediated 
surfactant secretion require further investigation. 
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CHAPTER IV 
VACUOLAR ATPases: POTENTIAL ROLES IN LUNG SURFACTANT SECRETION 
BY ALVEOLAR TYPE II CELLS 
 
4. 1 Abstract 
 
Lipid rafts organize protein and lipid machinery involved in many biological 
functions. The proteomic profile of alveolar type II cell lipid rafts revealed a small,  but 
diverse group of proteins involved in the regulation of pH, cell cycle and proliferation, 
metabolism, oxygen transport, and exocytosis. Vacuolar ATPases (V-ATPase) dominated 
lipid raft proteome and was examined for its role in surfactant secretion. The a1 and B 
subunits were enriched in lipid rafts and lamellar bodies. Bafilomycin A1 (Baf A1), an 
inhibitor of V-ATPase dissipated the lamellar body pH gradient as indicated by the loss 
of quinacrine accumulation. V-ATPase inhibition increased surfactant secretion. Baf A1-
stimulated secretion was effectively blocked by intracellular Ca2+-chelator, BAPTA-AM. 
This increase in secretion was inhibited by staurosporine and KN-62, the inhibitors of 
protein kinase C and calcium/calmodulin-dependent kinase II, respectively. Moreover, 
thapsigargin reduced the Baf A1-induced surfactant secretion, indicating the role of 
endoplasmic reticulum Ca2+ pool in Baf A1-mediated secretion. Further, the stimulation 
of alveolar type II cells with lung surfactant secretagogues increased pH in lamellar 
bodies. In summary, we conclude that V-ATPase regulates surfactant secretion via an 
increased Ca2+ mobilization and the activation of protein kinase C and Ca2+/calmodulin-
dependent kinase II. 
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4. 2 Introduction 
 
 Lipid rafts are specialized microdomains on the plasma membrane or subcellular 
membranes. Lipid rafts are enriched in saturated lipids including sphingolipids and 
cholesterol and specialized groups of proteins such as those which are acylated (Src 
kinases), post-translationally modified (flotillins) and cholesterol bound (caveolins).  
Lipid rafts can be isolated based on their Triton X-100 insolubility at 4oC. Cholesterol 
depletion resulted in decreased association of raft proteins and ultimately their associated 
functions.  
 Lipid rafts are implicated in exocytosis (1-7), endocytosis (8), signal transduction 
(9), membrane trafficking (10), bacterial entry (11) and virus budding (12). They are 
associated with a number of metabolic diseases including Alzheimer’s (13). 
The cuboidal alveolar type II cells synthesize, store and secrete lung surfactant, a 
lipid-rich surface active substance. The lung surfactant lowers the surface tension 
preventing the collapse of lungs. The secretion of surfactant is a relatively slow process 
when compared neurotransmitter release. Lung surfactant secretion is a highly regulated 
process. Our laboratory had earlier reported that SNAP-23 and syntaxin 2 were critical 
for lung surfactant secretion. Additionally, NSF and α-SNAP were implicated in 
surfactant secretion (14, 15). Our recent study indicated lipid rafts existed both on the 
lamellar body and plasma membranes. SNAP-23 associated with lipid rafts to a greater 
extent when compared syntaxin 2 and VAMP-2. Cholesterol depletion not only 
drastically reduced surfactant secretion but also fusion of lamellar bodies with plasma 
membrane.  Syntaxin 2 and SNAP-23 co-localised with CD44 clusters.    
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Lipid rafts contain only distinct proteins. The lipid raft proteomic profile would 
help to uncover the protein machinery contained in them and enable to further study these 
proteins in different functions. Lipid rafts proteomic studies have been undertaken in T-
cells (16, 17), human endothelial cells (18), mouse sperms (19), human smooth muscle 
cells (20) rat inestitinal mucosal cells (21), exocrine pancreatic cells (22) and HL-60 cells 
(23). These studies indicated that lipid rafts contained proteins involved in 
phosphorylation, cytoskeletal rearrangements, exocytosis, cell cycle and signal 
transduction (24).  
Vacuolar ATPases are multi-subunit enzymes that drive the movement of protons 
using the energy of the ATP hydrolysis. They are present on intracellular organelles 
including endosomes, lysosomes, secretory granules and synaptic vesicles and mediate 
the acification of these organelles. V-ATPases also exist on plasma membranes in some 
types of cells such as macrophages, neutrophils, kidney intercalated cells and osteoclasts. 
Organellar acidification is crucial for the dissociation of ligand-receptor complexes, 
processing of secretory proteins and accumulation of neurotransmitters. Extracellular 
acidification is crucial for bone resorption, urinary acidification or alkalinization and 
maintenance of intracellular pH. The mutations in genes coding for V-ATPase subunits 
contribute to a number of diseases (24-27). 
V-ATPases has been implicated in exocytosis.  The secretion of insulin in a3-
subunit knock-out mice was reduced. Several subunits interact with SNARE proteins in a 
number of cells systems (29-31). In yeast, integral membrane VO subunits a form a 
fusion pore during membrane fusion. (32, 33).  
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Lung lamellar bodies have lysosomal properties.  They maintain an internal acidic 
milieu owing to the presence of V-ATPases (34). The acidic lamellar body pH is crucial 
for surfactant protein B and C processing (35). NH4Cl or methylamine increased 
surfactant secretion. However, it should be noted that these agents not only increase 
lamellar body pH but also cytosolic pH (42).  
 In this study, we attempted to identify new components in type II cell lipid rafts 
using mass spectrometry. Our results revealed a number of novel proteins involved in 
energy metabolism, cytoskeletal re-arrangement, cell proliferation and pH regulation. We 
further studied the role of one of the identified proteins, V-ATPases in lung surfactant 
secretion and underlying mechanisms. 
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4.3 Materials and methods 
4.3.1 Reagents 
 Horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody, and protein 
molecular mass markers were from Bio-Rad (Hercules, CA). HRP-conjugated goat anti-
mouse antibody was from Jackson Immunologicals (West Grove, PA).  Porcine 
pancreatic elastase was obtained from Worthington (Lakewood, NJ), mouse anti-flotillin-
1 was from BD Biosciences (San Jose, CA), rabbit anti-v-ATPase a1 (H-140) and mouse 
monoclonal B1/2 were from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal 
mouse anti-Na+-K+ATPase α1-subunit antibodies were from Upstate Biotechnology 
(Lake Placid, NY). Bafilomycin A1 was from LC Laboratories (Woburn, MA). Enhanced 
Chemiluminiscence detection system was from GE Health Care (Piscataway, NJ). 
Methyl-3H-Choline chloride was from PerkinElmer (Waltham, MA). All the reagents and 
chemicals used for 2-D gel electrophoresis were from Bio-Rad.  
4.3.2 Alveolar type II cell Isolation 
 Type II cells were isolated from Sprague-Dawley male rat lungs as described 
earlier (7). Purity and viability of the cells were greater than 90 and 95%, respectively.  
4.3.3 Isolation of lipid rafts 
Following isolation, the type II cells were washed once with MEM and then with 
MBS (25 mM MES and 150 mM NaCl, pH 6.5) buffer twice. Lipid rafts were isolated 
exactly as described earlier (7). In brief, the cell were lysed in ice-cold 1% Triton X-100 
and incubated on ice for 45 min. For cholesterol depletion, type II cells were lysed with 
0.5% Triton X-100 and 0.5% (w/v) saponin. Equal amounts of proteins in 600 μl were 
used for isolation of lipid rafts. Ther lysates (in 600 μl) were mixed with equal volume of 
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80% sucrose and laid at bottom of the ultracentrifuge tube.  Similarly, 1200 μl of 30% 
and 5% sucrose were laid on top of 40% sucrose. The gradients were then subjected for 
raft isolation. Following rafts isolation, different fractions were collected from top to 
bottom of the gradients. First two fractions (1 and 2) of 600 μl each were drawn from top 
of the gradients. Three fractions (3, 4, and 5) of 400 μl each were collected.  
Subsequently, two fractions (6 and 7) of 600 μl were drawn. The pellet was dissolved in 
600 μl of lysis buffer. The fractions were probed for the raft marker protein, flotillin-1. 
Lipid rafts were consistently isolated from the interface between 5 and 30% sucrose 
gradients i.e., fraction 3. The raft fractions were diluted four times with MBS buffer, 
followed by centrifugation at 25,000 rpm. The pellet was resuspended in MBS buffer and 
stored at -800C until used. We consistently obtained ~125 µg of raft protein from 25 
million type II cells.  
4.3.4 2-dimensional (2-D) Gel Electrophoresis 
Lipid rafts fractions were first cleaned up using the ReadyPrep 2-D cleanup kit 
and the resuspended in 2-D rehydration/sample buffer (8 M Urea, 2% CHAPS, 50 mM 
DTT, 0.2% Bio-Lyte 3/10 ampolyte, 0.002% bromophenol blue). Precast immobilized 
pH gradient (IPG) strips (pH 3-10) were rehydrated and loaded with the protein samples 
for overnight at room temperature. The proteins were separated on the first dimension by 
isoelectric focusing (IEF) at room temperature until 40-60,000 Vhrs were reached. It took 
12-16 hours for IEF.  Following IEF, the IPG strips were equilibrated in SDS-PAGE 
equilibration buffer I [6 M Urea, 0.375 M Tris-HCl, pH 8.8, 2% SDS, 20% glycerol, 2% 
(w/v) DTT] for 10 min and then with buffer II (equilibration buffer I plus 2.5% (w/v) 
iodoacetamide] for additional 10 min.  The proteins were further separated on precast 8-
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16% polyacrylamide gels based on their molecular masses. The gels fixed with 40% (v/v) 
methanol and 10% (v/v) acetic acid for 1 hour, washed with sterile water for two times 
(10 min each) and stained for overnight in staining buffer [0.08% (w/v) coomassie 
brilliant blue G250; 1.6% (w/v) ortho-phosphoric acid; 8% (w/v) ammonium sulphate; 
20% (v/v) methanol]. The gels were then destained with 1% acetic acid several times 
until coomassie particles were removed. The gel was later scanned and proteins spots 
excised for trypsinolysis and mass spectrometry. 
4.3.5 Matrix-Assisted Laser Desorption/Ionisation-Time Of Flight (MALDI-TOF) 
mass spectrometry 
 The gel spots were first destained with 50% acetonitrile and then with 100% 
acetonitrile and 100 mM ammonium bicarbonate (ABC). The gels were subsequently 
rehydrated with freshly made reducing buffer (10 mM DTT, 25 mM ABC) for 1 hour at 
560C.  The proteins were subjected for alkylation for 1 hour (55 mM iodoacetamide in 25 
mM ABC) and then to dehydration and rehydration with 100% and 50% acetonitrile for 
additional 1.5 hours. Subsequently the proteins were subjected to trypsin digestion (8.3 
µg/ml in 25 mM ABC) for 4 hours at 370C. The proteins were then precipitated with 
0.1% trifluoroacetic acid. The trypsinized proteins were spotted onto MALDI plates and 
overlaid with freshly made matrix (5 mg/ml of alpha-cyano-4-hydroxycinnamic acid). 
For better mass accuracy, the calibration standards were spotted in neighboring wells of 
the plate. Peptide mass fingerprints were obtained on a mass spectrometer based on 
MALDI-TOF data (Voyager DE-PRO, Applied Biosystems) in the reflector mode. The 
post-acquisition processing was done using the Explorer software.  The spectra were 
smoothed by Gaussian method.   
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4.3.6 Database searching 
  The peptide mass spectra generated following mass spectrometry was searched 
against mass spectrometry protein sequence database using MASCOT software (Matrix 
Science Ltd., London). Peptide masses were searched against both mammalian and 
rodent databases. Peaks obtained due to keratin contamination were excluded from 
database searching. The proteins were identified according to their probability based 
MOlecular WEight SEarch (MOWSE) score. Only those proteins with high scores are 
included. The higher the score, the more likely is the confidence in the identification 
(p<0.05). The following parameters were set in the search process: only monoisotopic 
masses were included in the search, only one missed cleavage per peptide, variable 
modifications such as carbamidomethyl and propionamide of cysteines, oxidation of 
methionines, peptide mass tolerance ± 100 ppm, peptide charge state of 1+. All matching 
spectra were manually reviewed.  
4.3.7 Phosphatidylcholine (PC) secretion Assay 
 Overnight cultured cells were assayed for PC secretion exactly as described 
earlier (7). In brief, overnight cultured were washed to remove unattached cells. The cells 
were treated with Baf A1 for 1 hour.  A set of dishes were taken out for estimation of 
lipid secreted during this time (zero time). The cells were stimulated with a combination 
of secretagogues (100 µM ATP, 0.1 µM PMA and 10 µM terbutaline) for additional 2 
hours in the presence of inhibitor. Media and cell were collected and lipid extraction was 
exactly as described before (7). The amounts of lipids secreted were expressed as a 
percent of total lipids. The zero time secretion values were subtracted from control and 
stimulated values to arrive at a net basal and stimulated secretion.   
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 To study the role of thapsigargin on the Baf A1-induced PC secretion, the cells 
were pre-treated with 100 µM thapsigargin for 15 min and then with Baf A1. 
 To determine the activation of protein kinase C (PKC) and Ca2+/Calmodulin-
dependent Kinase II (CaMKII) following V-ATPase inhibition, overnight cultured type II 
cells were treated with 100 nM of staurosporine and 10 µM KN-62 to inhibit PKC and 
CaMKII, respectively in the presence of 20 nM Baf A1. The cells were then assayed for 
their secretory capabilities as described above. 
4.3.8 Quinacrine staining 
 Type II cells were plated at a density of 0.5-1x106 cells in 35 mm2 dishes. 
Following overnight culture in DMEM (supplemented with 10% FBS, non-essential 
amino acids, penicillin and streptomycin), the cells were washed to remove unattached 
cells.  Freshly made quinacrine was added to media at a final concentration of 10 µM. 
Lamellar body staining was examined  within 1-2 minutes upon addition of the dye using 
florescence microscope.  
For detecting the changes in lamellar body, overnight cultured type II cells were 
stimulated with lung surfactant secretagogues (200 µM ATP, 0.1 µM PMA and 10 µM 
terbutaline) for various times. At the end of incubation, the cells were loaded with 10 µM 
quinacrine for about one minute. The media was immediately decanted and the cells fixed 
with 4% paraformaldehyde.  Fluorescence was monitored by florescence microscopy 
(Nikon). We included unstimulated control cells for each of the time points to prevent 
bias with respect to loading and quenching of the dyes. The microscopic fields were 
chosen at random and at least 2-3 fields with about 8-10 cells in each field were selected 
for further analysis. The time lapse between capturing the images under both the 
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conditions (stimulated and unstimulated) for that time point was ≤ 5 min. During this 
time, we did not observe any quenching of the dye. Identical exposure settings were used 
for capturing images for each time-point. The images were captured with a 40X objective 
lens. Sometimes the order of capturing images between control and treated was reversed 
to check if there were any differences due to the time of capturing images.  In our hands, 
the order of capturing images did not reveal any differences when captured within this 
time. 
For quantitation, the intensity of quinacrine was studied using the Metavue 
software. In brief, the stained regions (in this case lamellar bodies) were carefully 
selected and integrated intensity of the quinacrine stained regions was measured and 
expressed as arbitrary units per cell. The intensity of all the cells was thus measured and 
the average intensity was calculated. Later, the intensity was expressed as per cent of 
control.   
4.3.9 MTT assay 
 The viability of the cells following V-ATPase inhibition was monitored using 
MTT assay exactly as described earlier (7).  
4.3.10 Statistical analysis  
 All the experiments were repeated atleast with 3 independent biological samples. 
Statistical significance was considered only when the p ≤ 0.05.  Student t test was used to 
compare the significant differences between the the control and treatment groups.  
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4.4 Results 
4.4.1 2-D gel electrphoresis 
 We isolated lipid rafts from alveolar type II cells and performed proteomic 
analysis to identify proteins present in lipid rafts. Alveolar type II cells were solubilized 
with 1% Triton X-100 and subjected to a sucrose gradient centrifugation as previously 
described (7). The isolated rafts were enriched in flotillin-1, a lipid raft marker but 
excluded Na+-K+-ATPase, a non-raft marker protein. (Fig. IV. 1A, fraction 3). 
Additionally, the association of flotillin-1 was cholesterol dependent which indicated the 
standardized isolation protocol (7). Raft proteins (500-600 µg) were separated on first 
dimension by IEF using a IPG strip (pH 3-10) and then by SDS-PAGE using a 8-16% 
gradient gel.  The gels were stained with colloidal coomassie blue (Fig. IV. 1B).  In 
addition to rodent database, which is a relatively small, we also searched human and 
mouse databases for the identification of proteins. Some of the identified proteins are 
shown in 2-D gel (Fig. IV. 1B).  The proteins were identified using probability based 
MOWSE scores. The results of the peptide mass fingerprinting are summarized in Table 
1. The list included cytoskeletal proteins, V-ATPases, phospholipid binding proteins and 
some mitochondrial enzymes. Because of their importance in lamellar body acidification, 
we chose V-ATPase for further studies. 
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Fig. IV. 1. 2-D gel electrophoresis of type II cell  lipid rafts: A) Confirmation of lipid 
rafts isolated from type II cells: Freshly isolated type II cells were lysed in the presence 
of 1% Triton X-100 (control) or 0.5% Triton X-100 and 0.5% (w/v) saponin (cholesterol 
depleted) at 40C for 45 minutes. Later, the lysate was subjected for sucrose gradient 
centrifugation. Seven Fractions were collected from the top. The pellet was dissolved in 
lysis buffer (fraction P).  The fractions were immunoblotted for flotillin-1, a raft marker 
protein and Na+-K+ ATPase, a non-raft marker protein. Shown are the representative 
pI 4.0 pI 10.0 
Mr 
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immunoblots. B) 2-D gel electrophoresis: Lipid rafts proteins were subjected 2-D gel 
electrophoresis. Later, the gels were stained with coomassie blue stain. Shown is a 
representative of 3 runs.  
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Table. IV. 1: Proteomic profile of lipid rafts isolated from alveolar type II cells 
Protein NCBI 
Accesion # 
Mr 
 (kDa) 
pI Peptides 
matched 
      / 
Searched
Sequence 
covered 
Mascot score 
       / 
Mascot 
threshold 
Vacuolar Acidification 
V-ATPase, V1  subunit A  AAC52410 68 5.46 23/103 36 97/67 
V-ATPase, V1 subunit B AAC52411 57 5.57 14/79 27 155/55 
V-ATPase,  VO subunit D1 Q5M7T6 40 4.89 8/23 26 79/55 
V-ATPase, V1 subunit E1 Q6PCU2 26 8.44 12/52 43 84/55 
V-ATPase, V1 subunit F BAB24692 13 5.52 8/35 63 97/55 
ATP synthesis     
F-ATPase  subunit β  1MABA 53 8.73 19/48 37 151/55 
F-ATPase, subunit E 1MABB 49 5.11 11/26 34 97/63 
Cytoskeleton-associated 
β -actin ATRTC 42 5.29 10/14 28 113/55 
Vimentin P31000 54 5.06 22/96 45 126/55 
SPFH domain family, 
member 2 
Q8BFZ9 38 5.37 10/10 25 157/63 
Cell Cycle and repair 
Prohibitin AAH72518 30 5.57 8/13 24 84/63 
Ca2+-dependent membrane binding 
Annexin A2 NP_06370 39 7.53 19/50 52 155/55 
Signal transduction 
Caveolin 1β AAL33580 17 4.97 7/19 31 76/55 
Miscellaneous 
Globin β1 AAB30298 16 7.98 8/46 58 81/55 
Hemoglobin subunit α-1/2 HBA_RAT 15 7.93 5/15 50 70/55 
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4.4.2 Association of V-ATPase subunits with lipid rafts 
 We first used western blot analysis to confirm the association of V-ATPase with 
lipid rafts. Each fraction from raft isolation was examined for V-ATPase a1 and B1/2 
subunits. As shown in Fig. IV. 2, B1/2 and a1 subunits were present mainly in raft 
fraction (fraction 3). Furthermore, depletion of cholesterol resulted in the dissociation of 
both subunits with lipid rafts. Our results indicated a genuine association of a1 and B1/2 
with lipid rafts in a cholesterol dependent manner.  
 
 
 
 
 
 
 
Fig. IV. 2. Association of V-ATPase subunits with lipid rafts: Type II cells were lysed 
in 1% Triton X-100 (control) or 0.5% Triton X-100 + 0.5% saponin (cholesterol 
depleted). Later, the lysates were subjected for raft isolation and various fractions were 
collected. Equal volumes of fractions were immunoblotted for v-ATPase a1 and B1/2 
subunits.  
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4.4.3 Differential expression of V-ATPase subunits 
 We then studied the subcellular localization of V-ATPase subunits.  
Immunoblotting revealed a much higher amount of a1 and B1/2 subunits in type II cell 
lysates when compared to lung homogenate (Fig. IV. 3). While plasma membrane 
fraction had a small amount of both subunits, lamellar body fractions contain abundant a1 
and B1/2 subunits.  
 
Fig. IV. 3. Western blots of V-ATPase subunits: Equal amount of total protein isolated 
from plasma membrane (PM), Lamellar bodies (LB), type II cells (T2), and lung tissue 
(LH) were immunoblotted for V-ATPase a1 and B1/2 subunits.  
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4.4.4 Effect of V-ATPase inhibition on lamellar body pH gradient and surfactant 
secretion 
 The acidic milieu in the lamellar bodies is required for processing of surfactant 
proteins and packaging of surfactant lipids (35, 42). Since V-ATPases were involved in 
the acidification or generation of the pH gradient across the lamellar body membrane, we 
studied if V-participate in surfactant secretion (34). We inhibited V-ATPase with Baf A1, 
a macrolide antibiotic isolated from Streptomyces griseus. Baf A1 is a specific and potent 
inhibitor of V-ATPase at nanomole concentrations. We ascertained the inhibition of V-
ATPase by monitoring the accumulation of quinacrine (34, 35). Type II cells were treated 
with 20 nM Baf A1 for various times.  The pH gradient was effectively dissipated within 
an hour. As shown in Fig. IV. 4A, in untreated type II cells, quinacrine accumulates in 
the acidic lamellar bodies. Fluorescence in the cells treated with Baf A1 was lost, 
indicating an increase in lamellar body pH.  
 To investigate the effect of V-ATPase inhibition on surfactant secretion, type II 
cells were treated with Baf A1 and surfactant secretion measured. Baf A1 increased 
surfactant secretion to 4.30 ± 0.29 when compared to 1.75 ± 0.21 percent in untreated 
cells (Fig. IV. 4B).  The increase in secretion was not due to deleterious effects as cell 
viability was unchanged in the Baf A1-treated cells (data not shown). Additionally, 
stimulated surfactant secretion was also examined. Lung secretagogues were added 
following 1 hour of treatment with Baf A1 since by that time the pH gradient was lost. 
When type II cells were stimulated with a combination of secretagogues, Baf A1 slightly 
affected surfactant secretion. This probably is because the secretion had reached a 
saturation level under stimulated conditions.  
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Fig. IV.4. Effect of Baf A1 on the pH gradient of lamellar bodies and surfactant 
secretion: A) Overnight cultured cells were treated without or with 20 nM Baf A1 for 1 
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hour. Later the quinacrine was added at a final concentration of 10 µM. Fluorescence 
microscopy was undertaken to monitor quinacrine staining. Shown are the representative 
images of 3 biological independent cell preparations. Scale bar: 40 µm B) PC secretion: 
Freshly isolated type II cells were labeled with [3H]-choline overnight. Later, cells were 
treated with 20 nM Baf A1 for 1 hour. The cells were then stimulated with a combination 
of 100 µM ATP; 10 µM terbutaline and 0.1µM PMA for 2 additional hours. Secreted 
lipids were assayed and expressed as per cent of total lipids. Shown is means ± SE. *P ≤ 
0.05 v.s control (Student t test n ≥ 3). Open bars, control; shaded bars, Baf A1.  
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4.4.5 Effect of Ca2+ chelators and thapsigargin on V-ATPase-mediated surfactant 
secretion  
In a quest to understand the mechanisms of Baf A1-induced increase in 
surrfactant secretion, we first explored the possibility of an increase in intracellular Ca2+ 
([Ca2+]i) as one of the reasons.  To this end, type II cells were pre-treated with BAPTA-
AM to chelate intracellular Ca2+ and then treated with Baf A1. BAPTA-AM slightly 
increased secretion consistent with an earlier report (36). BAPTA-AM significantly 
decreased Baf A1-stimulated secretion, indicating mobilization of intracellular Ca2+ 
following V-ATPase inhibition (Fig. IV. 5A).  
Endoplasmic reticulum (ER) is one of the Ca2+ stores in cells.   Ca2+-ATPase is a 
Ca2+ channel on ER membrane responsible for the accumulation of Ca2+ in ER. We 
depleted the ER Ca2+ pool by inhibiting the Ca2+-ATPase using thapsigargin. There were 
no differences in secretion following treatment with thapsigargin when compared with 
the control (Fig. IV. 5). However, Baf A1-mediated secretion was effectively inhibited by 
thapsigargin.  
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Fig. IV. 5. Effect of Ca2+ chelators and thapsigargin on V-ATPase mediated- 
surfactant secretion: Overnight cultured type II cells were treated with Baf A1 in the 
presence or absence of intracellular Ca2+-chelator, A) BAPTA-AM (50 µM) and B) ER 
Ca2+-ATPase inhibitor, thapsigargin (TPG; 100 µM ). Data shown are means ± SE. 
*P<0.05 v.s control; #P<0.05 v.s Baf A1 (Student t test n ≥ 3). Numbers shown in the 
bars indicated the number of independent cell preparations.  
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4.4.6 Effect of PKC and CaMKII inhibition on V-ATPase-mediated surfactant 
secretion  
 An increase in intracellular Ca2+ may activate protein kinase C (PKC) and 
Ca2+/calmodulin-dependent kinase II (CaMKII), which have been shown to be involved 
on surfactant secretion. We thus examined whether the inhibition of PKC and CaMKII 
would block the Baf A1-mediated secretion. Staurosporine and KN-62 were used to 
inhibit PKC and CaMKII, respectively. Both agents effectively inhibited the Baf A1- 
mediated increase in surfactant secretion (Fig. IV. 6). The inhibitors alone had no effect. 
 Surfactant secretion can be stimulated through β2-adrenergic receptors and the 
activation of protein kinase A. If Baf A1 elicits its effect by Ca2+, PKC/CaMKII 
pathways, an additive effect should be observed when Baf A1 and terbutaline (β2 
agonist) were used together. Indeed, the addition of Baf A1 and terbutaline resulted in an 
additive increase in secretion (Fig. IV. 6).  
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Fig. IV. 6 Effect of PKC and CaMKII inhibitors on V-ATPase-mediated secretion: 
Overnight cultured type II cells were treated with Baf A1 in the presence or absence of 
A) Staurosporine (100 nM) or B) KN-62 (10 µM) and C) Terbutaline. Later PC secretion 
assay was done. Data shown are Means ± SE. *P<0.05 v.s control; #P<0.05 v.s Baf A1 
(Student t test n ≥3).  Numbers shown in the bars indicated the number of independent 
cell preparations. 
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4.9 V-ATPase is inhibited during lamellar body exocytosis  
 Finally we asked if there were a physiological relevance of V-ATPase inhibition 
in surfactant secretion. We examined the effect of type II cell stimulation on the pH 
gradient across lamellar body membrane. We stimulated type II cells with a combination 
of lung surfactant secretagogues for various times and monitored the lamellar body pH by 
the accumulation of quinacrine.  A gradual decrease in accumulation of the dye was 
observed in the lamellar bodies following stimulation with secretagogues (Fig. IV.7A). 
The quantitation of the intensity of fluorescence revealed  a ~ 50% decrease at 60 min 
(Fig. IV. 7B). 
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Fig. IV. 7. Monitoring of lamellar body pH following stimulation of type II cells: 
Overnight cultured type II cells were stimulated with a combination of ATP (200 μM) 
and terbutaline (20 μM) for various times as indicated in the figure. At the end of 
incubation time, the cells were loaded with 10 μM quinacrine for about one minute. The 
cells were then immediately fixed before microscopy.  A) Shown are the representative 
images indicating the changes in quinacrine accumulation patterns as a function of time. 
Scale bar: 40 μM. B) The intensity of quinacrine staining was quantified and expressed as 
percent of control. Shown are means ± SEM (n = 3 independent cell preparations).  
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4. 5 Discussion 
 Type II cells are involved in synthesis, storage and secretion of lung surfactant. 
Our previous study indicated the role of lipid rafts in surfactant secretion (7). However, 
data is lacking on the entire protein components of lipid rafts in many cell types including 
type II cells. The results uncovered the proteomic profile of lipid rafts isolated from type  
II cells. The proteomic profile indicated proteins involved in diverse processes. V-
ATPases subunits were present in the lipid rafts and hence this protein was studied in 
detail for its role in surfactant secretion. Our results indicated that inhibition of V-ATPase 
triggers surfactant secretion by mobilizing [Ca2+]i which activate PKC and CaMKII. 
 Type II cell lipid raft proteins included those involved in acidification (V-
ATPases), metabolism (ATP synthases) and cellular proliferation and differentiation 
(prohibitin), phospholipids-binding proteins (annexin A2), cytoskeletal proteins (actin), 
and oxygen exchange (globin beta1). Many of these proteins were also found in lipid 
rafts of other cells (16-24).  Our studies indicated that type II cell lipid rafts contained a 
small set of proteins. However, the numbers of proteins identified in other studies were 
higher than this study mainly due to use of tandem mass spectrometry in those studies.   
 The presence of V-ATPases in the type II cell lipid rafts appears intriguing. The 
preponderance of V-ATPase in the lipid rafts of other cells have been reported (37-39). 
These proteins have specialized functions on the plasma membranes apart from 
intracellular membranes. Our previous studies have shown that the lipid raft marker 
proteins, flotillin-1 and -2 were present on lamellar bodies, indicating that lipid rafts exist 
in intracellular compartments (7).  
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Lamellar bodies in type II cells maintain acidic milieu (pH 5.5-6.0) due to the V-
ATPase activity (34, 40). The acidic pH was confirmed by accumulation of dyes such as 
quinacrine and acridine orange (34, 42). Acidic pH in the lamellar body is essential for 
packaging of surfactant lipids, surfactant protein-A dependent aggregation of lipids, 
proteolytic processing of surfactant protein-B and C and Ca2+ uptake (34, 41-43). V-
ATPases on the organelles generate transvesicular proton-electrochemical potential 
gradient (Δψv) and pH gradient (ΔpHv).  The treatment of type II cells with methylamine 
and ammonium chloride increases lamellar body pH and enhances surfactant secretion 
(42).  However, methylamine and ammonium chloride also increase cytosolic pH 
transiently. Our results indicated that the dissipation of lamellar body pH by Baf A1 
increases surfactant secretion suggesting that the increase of surfactant secretion is due to 
an increase in lamellar body pH but not due to cytosolic pH. Inhibition of V-ATPase 
resulted in decreased exocytosis in PC12, GH3, pancreatic alpha and beta cells (45-49) 
whereas increased secretion in pituitary, glial, macrophages and neutrophils (50-52).  
Interestingly in some cases, there was no effect of V-ATPase inhibition on secretion (49, 
53). It thus appears different cell type respond differently to V-ATPase inhibition. 
  Intracellular Ca2+ can be altered by influx of Ca2+ from extracellular mileu and 
mobilization of Ca2+ from intracellular pools. Lamellar bodies contain high levels of Ca2+ 
and could be one of the potential intracellular sources. Our results have shown that 
intracellular Ca2+ chelation abrogated the Baf A1-induced secretion. Lysosomal pH 
dissipation in macrophages led to gradual loss of lysosomal Ca2+ with a simultaneous 
increase in cytosolic levels (54). A similar process may occur in lamellar bodies since V-
ATPase were predominantly expressed on lamellar body membrane and its inhibition led 
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to the dissipation of pH gradient.  It is possible that released Ca2+ from lamellar bodies 
increases localized Ca2+ concentration and thus increase surfactant secretion. In fact, it 
has been reported that the Ca2+ concentration in exocytotic lamellar bodies is higher than 
that in perinuclear lamellar bodies (55). Similarly, in adrenal chromaffin cells, increase in 
vesicular pH induced release of Ca2+ and increased secretion (56).  
Depletion of ER pool inhibited the V-ATPase-mediated increase in secretion 
indicating the cross-talk between ER and lamellar body Ca2+ pools. Our study is 
supported by previous reports which indicated that small, localized changes in Ca2+ 
induce global Ca2+ waves due to interplay between different Ca2+ pools. In arterial 
smooth muscle cells, NAADP increases Ca2+ release from Baf A1-sensitive 
compartment, which in turn further induces Ca2+ release from sarcoplasmic reticulum by 
calcium induced calcium release owing to the close apppsition of these two pools (57). It 
is possible that such an apposition exist in type II cells. 
When type II cells were treated with PKC and CaMKII inhibitors, we observed an 
inhibition in Baf A1-induced surfactant secretion. Similar results were reported for 
lysosomal secretion in macrophages. (58). Our results thus supported the idea that the V-
ATPase mediated surfactant secretion is mediated by PKC and CaMKII and that the  
activation was due to  increase in [Ca2+]i .  
 We then asked if the V-ATPase activity was modulated during normal 
physiological conditions.  The accumulation of quinacrine dye gradually decreased when 
the cells were stimulated with lung surfactant secretagogues. When quinacrine 
accumulation was quantified, we found ~ 50% reduction in intensity. It should be noted 
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that this is an average intensity of all the lamellar bodies in type II cells irrespective of 
whether there were undergoing exocytosis. 
 In summary, we propose the following model for V-ATPase mediated-surfactant 
secretion. V-ATPase mediates the acidification of lamellar bodies. Inhibition of V-
ATPase results dissipation of lamellar body pH gradient. The increase in lamellar body 
pH results in mobilization of Ca2+ from lamellar bodies, leading to an increase in 
cytosolic free Ca2+. Such an increase further releases Ca2+ from the ER pool. The net 
surge on Ca2+ concentration activates PKC and CaMKII. The activation of these enzymes 
finally results in increased surfactant secretion.   
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Fig. IV. 8. Schematic representation of proposed events following V-ATPase 
inhibition: 
In this model, following V-ATPase inhibition by Baf A1, we propose that there is 
mobilization of Ca2+ from lamellar bodies. The small localized changes in Ca2+ 
concentration leads to further release of Ca2+ from  ER store (probably by activation of 
RyR). The global increase in Ca2+ concentration leads to activation of PKC and CaMKII 
leading to their activation and finally increased surfactant secretion. 
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CHAPTER V 
 
SUMMARY AND CONCLUSIONS 
 Type II cells synthesize, store and secrete lung surfactant. Earlier studies 
indicated that annexin A2, syntaxin 2, SNAP-23, VAMP-2, NSF and α-SNAP were 
involved in surfactant secretion. However, their organization on the cell membrane was 
not studied. The present study was designed to investigate the role of lipid rafts in the 
organization of surfactant secretion protein machinery.  In the second part of work, 
flotillins, the lipid rafts marker proteins were selected for investigating their roles in 
surfactant secretion. Finally, the proteomic profiling of lipid rafts was performed to 
unravel the protein components of lipid rafts. Various subunits of V-ATPase were found 
in the proteomic profile along with other proteins. We have studied in detail the role of 
V-ATPases in regulating lung surfactant secretion. 
 We studied the expression profiles of flotillins and caveolins, the lipd raft marker 
proteins in isolated type II cells and rat lung tissue sections. Our results indicated that 
type II cells express flotillins but not caveolins and hence these proteins were used for 
confirming lipid rafts isolation. Lipid rafts were isolated based on their ability to resist 
1% Triton X-100 solubilization and floatation on discontinous sucrose gradients. Isolated 
lipid rafts were characterized by enrichment of flotillin-1 and -2 and high cholesterol 
content. Furthermore, Na+-K+ATPase, a non-raft marker protein was completely 
excluded from lipid raft fractions. SNARE proteins were enriched in lipid rafts in a 
cholesterol dependent manner. Cholesterol depletion reduced surfactant secretion, fusion  
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pore formation and membrane fusion. Hence, lipid rafts integrity was essential for all 
these processes. Additionally, SNARE proteins co-localised with CD44 clusters. Annexin 
A2 was associated with lipid rafts in a Ca2+-dependent manner and also with CD44 
clusters.  The results suggest that lipid rafts might provide an amicable atmosphere for 
SNARE protein interactions and organize membrane fusion machinery.  
 Flotillin-1 and -2 were highly enriched in type II cells when compared with type I 
cells. Additionally, their expression was abundant on plasma membranes and lung 
lamellar bodies, indicating that lipid rafts existed in the intracellular compartments also. 
We further studied the role of these proteins in surfactant secretion. To this end, the 
expression of flotillins was silenced using adenovirus-mediated RNAi. We successfully 
silenced the expression of flotillins in type II cells and the lung cell line, L2. Flotillin-2 
but not -1 silencing reduced surfactant secretion by type II cells. To further undertand the 
mechanism of the decrease, lipid rafts were isolated following knockdown of flotillins in 
L2 cells. When analysed for SNARE protein association with lipid rafts, we did not find 
any significant differences following flotillin-1 and -2 silencing, indicating that SNARE 
protein association with lipid rafts was independent of flotillins. Since flotillins were 
involved with cholesterol homeostasis, we have assayed for cholesterol contents 
following silencing of flotillins. Cholesterol levels were unchanged after silencing. Thus 
it appears that flotillin-2 affects surfactant secretion independent of SNARE protein 
association and raft formation.  
 Lipid rafts contain only specific proteins, which are involved in diverse functions. 
We hence studied the proteomic profile of lipid rafts by mass spectrometry. Our results 
revealed that lipid rafts proteins are associated with vacuolar acidification, energy 
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metabolism, oxygen exchange and cell cycling. We selected V-ATPases, to study their 
roles in surfactant secretion. Following inhibition of V-ATPase by Baf A1, the lamellar 
body pH gradient was dissipated as indicated by the loss of quinacrine statining. V-
ATPase inhibition resulted in increased surfactant secretion when compared with 
controls. The V-ATPase mediated increase in secretion was effectively inhibited by 
intracellular Ca2+-chelator suggesting the mobilization of intracellular Ca2+ following V-
ATPase inhibition. Additionally, staurosporine, and KN-62, inhibitors of PKC and 
CaMKII, respectively inhibited the V-ATPase mediated increase in secretion, indicating 
the activation of these enzymes following V-ATPase inhibition. When lamellar body pH 
was monitored following stimulation with a combination of secretagogues, we found a 
gradual increase in lamellar body pH, indicating that V-ATPase activity might be reduced 
during surfacatant secretion. Thus, we conclude that V-ATPase regulates surfactant 
secretion by type II cells.  We proposed a mechanism of V-ATPase mediated surfactant 
secretion.  
 In summary, we for the first time implicated the role of lipid rafts in the 
organization of surfactant protein secretion machinery. Further, flotillin-2 had been found 
to be involved in surfactant secretion independent of lipid raft formation. Finally, V-
ATPase, one of the proteins identified in the proteomic profile of lipid rafts has been 
shown to regulate surfactant secretion.  
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Scope and Method of Study:  
 The present study was initiated to elucidate the role of lipid rafts in lung 
surfactant secretion. Lipid rafts were isolated and probed for the association of 
SNARE proteins. Cholesterol depletion was done to study its role in modulating 
the surfactant secretion and membrane fusion. Flotillin proteins were silenced to 
examine their role in surfactant secretion. Finally, we determined the proteomic 
profile of type II cell lipid rafts to identify novel proteins in this unique 
subproteome and study the roles of one of the identified proteins, namely, v-
ATPases, in surfactant secretion. We have used a number of techniques including 
RT-PCR, immunoblotting, immunoflorescence, secretion assay, membrane fusion 
assay, isolation of plasma membrane and lamellar bodies, and RNA interference 
to address the biological phenomenon.  
 
Findings and Conclusions:   
1. SNARE proteins were differentially associated with lipid rafts in a cholesterol-
dependent manner. 
2. Cholesterol depletion drastically reduced surfactant secretion, membrane fusion 
and fusion pore formation. 
3. SNARE proteins were associated with CD44 clusters.  
4. Flotillin-2 but not -1 reduced surfactant secretion. 
5. Flotillin (s) did not affect the association of SNARE proteins with rafts. 
6. Lipid raft formation was not altered by knockdown of flotillin-1 and -2. 
7. Type II cell lipid raft proteome contained proteins involved in cell proliferation, 
pH regulation and energy metabolism. 
8. V-ATPases mediate the acidification of lamellar bodies and V-ATPase inhibition 
leads to increased surfactant secretion.  
9. V-ATPase inhibition leads to the mobilization of Ca2+ from lamellar bodies, 
which in turn cause further release of Ca2+ from ER. The net surge activates 
protein kinase C and Ca2+/calmodulin-dependent kinase II leading to increased 
secretion.  
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